SARS-CoV-2 Spike

Created: June 5, 2022, 6:35 a.m. at 06:35

Models Name Description GMQE QSQE Seq Id Coverage Range Method Resolution Oligo-state Ligands Found by Seq Similarity
6wpt.1.A
spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state)
 0.68 0.82 100.00 0.96 1-1230 EM 3.70 homo-trimer 35 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUC HHblits 0.62
6wpt.1.C
spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state)
 0.69 0.82 100.00 0.96 1-1230 EM 3.70 homo-trimer 35 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUC HHblits 0.62
7q0a.1.A
Spike glycoprotein,Spike ectodomain,Spike protein S2'
SARS-CoV-2 Spike ectodomain with Fab FI3A
 0.70 0.83 99.67 0.96 32-1273 EM 0.00 homo-trimer 27 x NAG, 11 x NAG-NAG BLAST 0.62
7q0a.1.B
Spike glycoprotein,Spike ectodomain,Spike protein S2'
SARS-CoV-2 Spike ectodomain with Fab FI3A
 0.71 0.83 99.67 0.96 32-1273 EM 0.00 homo-trimer 27 x NAG, 11 x NAG-NAG BLAST 0.62
7q0a.1.C
Spike glycoprotein,Spike ectodomain,Spike protein S2'
SARS-CoV-2 Spike ectodomain with Fab FI3A
 0.69 0.83 99.67 0.96 32-1273 EM 0.00 homo-trimer 27 x NAG, 11 x NAG-NAG BLAST 0.62
7qdh.1.A
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:D614G mutant 1-up
 0.65 0.81 99.27 0.96 34-1272 EM 4.20 homo-trimer 24 x NAG, 10 x NAG-NAG BLAST 0.61
7qdh.1.B
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:D614G mutant 1-up
 0.65 0.81 99.27 0.96 34-1272 EM 4.20 homo-trimer 24 x NAG, 10 x NAG-NAG BLAST 0.61
7qdh.1.C
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:D614G mutant 1-up
 0.66 0.81 99.27 0.96 34-1272 EM 4.20 homo-trimer 24 x NAG, 10 x NAG-NAG BLAST 0.61
7qdg.1.A
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:A222V + S:D614G mutant 1-up
 0.66 99.19 0.96 34-1272 EM 3.40 homo-trimer 24 x NAG, 1 x NDG, 10 x NAG-NAG, 1 x NDG-NAG BLAST 0.61
7qdg.1.B
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:A222V + S:D614G mutant 1-up
 0.67 99.19 0.96 34-1272 EM 3.40 homo-trimer 24 x NAG, 1 x NDG, 10 x NAG-NAG, 1 x NDG-NAG BLAST 0.61
7qdg.1.C
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:A222V + S:D614G mutant 1-up
 0.67 99.19 0.96 34-1272 EM 3.40 homo-trimer 24 x NAG, 1 x NDG, 10 x NAG-NAG, 1 x NDG-NAG BLAST 0.61
7qdh.1.A
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:D614G mutant 1-up
 0.66 98.94 0.96 34-1273 EM 4.20 homo-trimer 24 x NAG, 10 x NAG-NAG HHblits 0.61
7qdh.1.B
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:D614G mutant 1-up
 0.66 98.94 0.96 34-1273 EM 4.20 homo-trimer 24 x NAG, 10 x NAG-NAG HHblits 0.61
7qdh.1.C
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:D614G mutant 1-up
 0.66 98.94 0.96 34-1273 EM 4.20 homo-trimer 24 x NAG, 10 x NAG-NAG HHblits 0.61
7q0a.1.A
Spike glycoprotein,Spike ectodomain,Spike protein S2'
SARS-CoV-2 Spike ectodomain with Fab FI3A
 0.70 99.43 0.96 30-1272 EM 0.00 hetero-3-1-1-mer 27 x NAG, 11 x NAG-NAG HHblits 0.62
7q0a.1.B
Spike glycoprotein,Spike ectodomain,Spike protein S2'
SARS-CoV-2 Spike ectodomain with Fab FI3A
 0.71 99.43 0.96 30-1272 EM 0.00 hetero-3-1-1-mer 27 x NAG, 11 x NAG-NAG HHblits 0.62
7q0a.1.C
Spike glycoprotein,Spike ectodomain,Spike protein S2'
SARS-CoV-2 Spike ectodomain with Fab FI3A
 0.69 99.43 0.96 30-1272 EM 0.00 hetero-3-1-1-mer 27 x NAG, 11 x NAG-NAG HHblits 0.62
7qdg.1.A
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:A222V + S:D614G mutant 1-up
 0.67 98.86 0.96 34-1273 EM 3.40 homo-trimer 24 x NAG, 1 x NDG, 10 x NAG-NAG, 1 x NDG-NAG HHblits 0.61
7qdg.1.B
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:A222V + S:D614G mutant 1-up
 0.68 98.86 0.96 34-1273 EM 3.40 homo-trimer 24 x NAG, 1 x NDG, 10 x NAG-NAG, 1 x NDG-NAG HHblits 0.61
7qdg.1.C
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:A222V + S:D614G mutant 1-up
 0.68 98.86 0.96 34-1273 EM 3.40 homo-trimer 24 x NAG, 1 x NDG, 10 x NAG-NAG, 1 x NDG-NAG HHblits 0.61
6z97.1.C
Spike glycoprotein,Fibritin
Structure of the prefusion SARS-CoV-2 spike glycoprotein
 0.69 99.67 0.96 32-1272 EM 0.00 homo-trimer 27 x NAG, 11 x NAG-NAG BLAST 0.62
6zhd.1.B
Spike glycoprotein,Fibritin
H11-H4 bound to Spike
 0.70 99.67 0.96 32-1272 EM 3.70 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG BLAST 0.62
6z97.1.B
Spike glycoprotein,Fibritin
Structure of the prefusion SARS-CoV-2 spike glycoprotein
 0.71 99.67 0.96 32-1272 EM 0.00 homo-trimer 27 x NAG, 11 x NAG-NAG BLAST 0.62
6z97.1.A
Spike glycoprotein,Fibritin
Structure of the prefusion SARS-CoV-2 spike glycoprotein
 0.70 99.67 0.96 32-1272 EM 0.00 homo-trimer 27 x NAG, 11 x NAG-NAG BLAST 0.62
6zhd.1.A
Spike glycoprotein,Fibritin
H11-H4 bound to Spike
 0.71 99.67 0.96 32-1272 EM 3.70 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG BLAST 0.62
6zhd.1.C
Spike glycoprotein,Fibritin
H11-H4 bound to Spike
 0.70 99.67 0.96 32-1272 EM 3.70 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG BLAST 0.62
6z97.1.C
Spike glycoprotein,Fibritin
Structure of the prefusion SARS-CoV-2 spike glycoprotein
 0.69 99.35 0.96 30-1272 EM 0.00 homo-trimer 27 x NAG, 11 x NAG-NAG HHblits 0.61
6zhd.1.B
Spike glycoprotein,Fibritin
H11-H4 bound to Spike
 0.70 99.35 0.96 30-1272 EM 3.70 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG HHblits 0.61
6z97.1.B
Spike glycoprotein,Fibritin
Structure of the prefusion SARS-CoV-2 spike glycoprotein
 0.71 99.35 0.96 30-1272 EM 0.00 homo-trimer 27 x NAG, 11 x NAG-NAG HHblits 0.61
6z97.1.A
Spike glycoprotein,Fibritin
Structure of the prefusion SARS-CoV-2 spike glycoprotein
 0.70 99.35 0.96 30-1272 EM 0.00 homo-trimer 27 x NAG, 11 x NAG-NAG HHblits 0.61
6zhd.1.A
Spike glycoprotein,Fibritin
H11-H4 bound to Spike
 0.71 99.35 0.96 30-1272 EM 3.70 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG HHblits 0.61
6zhd.1.C
Spike glycoprotein,Fibritin
H11-H4 bound to Spike
 0.70 99.35 0.96 30-1272 EM 3.70 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG HHblits 0.61
7ad1.1.A
Spike glycoprotein,Envelope glycoprotein,Spike glycoprotein,Envelope glycoprotein,SARS-CoV-2 S protein
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(One up trimer)
 0.70 99.51 0.96 32-1273 EM 0.00 homo-trimer 10 x NAG, 10 x NAG-NAG BLAST 0.62
7ad1.1.B
Spike glycoprotein,Envelope glycoprotein,Spike glycoprotein,Envelope glycoprotein,SARS-CoV-2 S protein
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(One up trimer)
 0.69 99.51 0.96 32-1273 EM 0.00 homo-trimer 10 x NAG, 10 x NAG-NAG BLAST 0.62
7ad1.1.C
Spike glycoprotein,Envelope glycoprotein,Spike glycoprotein,Envelope glycoprotein,SARS-CoV-2 S protein
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(One up trimer)
 0.69 99.51 0.96 32-1273 EM 0.00 homo-trimer 10 x NAG, 10 x NAG-NAG BLAST 0.62
7ns6.1.G
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies
 0.70 99.43 0.96 32-1272 EM 0.00 hetero-6-6-mer 46 x NAG, 2 x NAG-NAG-BMA BLAST 0.62
7a4n.1.A
Spike glycoprotein,Fibritin
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(S-closed trimer)
 0.69 99.51 0.96 32-1272 EM 0.00 homo-trimer 15 x NAG, 3 x NAG-NAG BLAST 0.62
7ns6.1.G
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies
 0.70 99.10 0.96 30-1272 EM 0.00 hetero-6-6-mer 46 x NAG, 2 x NAG-NAG-BMA HHblits 0.61
6zgf.1.A
Spike glycoprotein
Spike Protein of RaTG13 Bat Coronavirus in Closed Conformation
 0.71 97.65 0.96 32-1273 EM 0.00 homo-trimer 27 x NAG, 21 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-BMA, 3 x NAG-FUC BLAST 0.61
7ad1.1.A
Spike glycoprotein,Envelope glycoprotein,Spike glycoprotein,Envelope glycoprotein,SARS-CoV-2 S protein
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(One up trimer)
 0.70 99.02 0.96 30-1273 EM 0.00 homo-trimer 10 x NAG, 10 x NAG-NAG HHblits 0.61
7ad1.1.B
Spike glycoprotein,Envelope glycoprotein,Spike glycoprotein,Envelope glycoprotein,SARS-CoV-2 S protein
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(One up trimer)
 0.69 99.02 0.96 30-1273 EM 0.00 homo-trimer 10 x NAG, 10 x NAG-NAG HHblits 0.61
7ad1.1.C
Spike glycoprotein,Envelope glycoprotein,Spike glycoprotein,Envelope glycoprotein,SARS-CoV-2 S protein
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(One up trimer)
 0.69 99.02 0.96 30-1273 EM 0.00 homo-trimer 10 x NAG, 10 x NAG-NAG HHblits 0.61
7a4n.1.A
Spike glycoprotein,Fibritin
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(S-closed trimer)
 0.69 99.02 0.96 30-1272 EM 0.00 homo-trimer 15 x NAG, 3 x NAG-NAG HHblits 0.61
6zgf.1.A
Spike glycoprotein
Spike Protein of RaTG13 Bat Coronavirus in Closed Conformation
 0.70 96.68 0.96 32-1274 EM 0.00 homo-trimer 27 x NAG, 21 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-BMA, 3 x NAG-FUC HHblits 0.61
7zr8.1.A
Spike glycoprotein,Fibritin
OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement)
 0.05 98.94 0.95 32-1272 EM 0.00 hetero-1-1-1-mer 1 x NAG BLAST 0.61
7zr9.1.A
Spike glycoprotein,Fibritin
OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
 0.71 98.94 0.95 32-1272 EM 0.00 hetero-3-3-3-mer 30 x NAG, 12 x NAG-NAG BLAST 0.61
7zrc.1.B
Spike glycoprotein,Fibritin
OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE
 0.72 98.94 0.95 32-1272 EM 0.00 hetero-3-3-3-mer 28 x NAG, 12 x NAG-NAG BLAST 0.61
7zr9.1.B
Spike glycoprotein,Fibritin
OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
 0.72 98.94 0.95 32-1272 EM 0.00 hetero-3-3-3-mer 30 x NAG, 12 x NAG-NAG BLAST 0.61
7zr9.1.C
Spike glycoprotein,Fibritin
OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
 0.72 98.94 0.95 32-1272 EM 0.00 hetero-3-3-3-mer 30 x NAG, 12 x NAG-NAG BLAST 0.61
7zr7.1.C
Spike glycoprotein,Fibritin
OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
 0.72 98.94 0.95 32-1272 EM 0.00 hetero-3-3-3-mer 30 x NAG, 12 x NAG-NAG BLAST 0.61
7zrc.1.A
Spike glycoprotein,Fibritin
OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE
 0.73 98.94 0.95 32-1272 EM 0.00 hetero-3-3-3-mer 28 x NAG, 12 x NAG-NAG BLAST 0.61
7zr7.1.B
Spike glycoprotein,Fibritin
OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
 0.72 98.94 0.95 32-1272 EM 0.00 hetero-3-3-3-mer 30 x NAG, 12 x NAG-NAG BLAST 0.61
7zr8.1.A
Spike glycoprotein,Fibritin
OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement)
 0.05 98.53 0.96 30-1272 EM 0.00 hetero-1-1-1-mer 1 x NAG HHblits 0.61
7zr9.1.A
Spike glycoprotein,Fibritin
OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
 0.72 98.53 0.96 30-1272 EM 0.00 hetero-3-3-3-mer 30 x NAG, 12 x NAG-NAG HHblits 0.61
7zrc.1.B
Spike glycoprotein,Fibritin
OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE
 0.72 98.53 0.96 30-1272 EM 0.00 hetero-3-3-3-mer 28 x NAG, 12 x NAG-NAG HHblits 0.61
7zr9.1.B
Spike glycoprotein,Fibritin
OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
 0.72 98.53 0.96 30-1272 EM 0.00 hetero-3-3-3-mer 30 x NAG, 12 x NAG-NAG HHblits 0.61
7zr9.1.C
Spike glycoprotein,Fibritin
OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
 0.72 98.53 0.96 30-1272 EM 0.00 hetero-3-3-3-mer 30 x NAG, 12 x NAG-NAG HHblits 0.61
7zr7.1.C
Spike glycoprotein,Fibritin
OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
 0.72 98.53 0.96 30-1272 EM 0.00 hetero-3-3-3-mer 30 x NAG, 12 x NAG-NAG HHblits 0.61
7zrc.1.A
Spike glycoprotein,Fibritin
OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE
 0.73 98.53 0.96 30-1272 EM 0.00 hetero-3-3-3-mer 28 x NAG, 12 x NAG-NAG HHblits 0.61
7zr7.1.B
Spike glycoprotein,Fibritin
OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
 0.72 98.53 0.96 30-1272 EM 0.00 hetero-3-3-3-mer 30 x NAG, 12 x NAG-NAG HHblits 0.61
7fjn.1.A
Spike glycoprotein,Envelope glycoprotein
Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with two T6 Fab
 0.68 99.02 0.95 35-1273 EM 0.00 hetero-3-2-2-mer 25 x NAG BLAST 0.61
7fjn.1.C
Spike glycoprotein,Envelope glycoprotein
Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with two T6 Fab
 0.67 99.02 0.95 35-1273 EM 0.00 hetero-3-2-2-mer 25 x NAG BLAST 0.61
7fjn.1.A
Spike glycoprotein,Envelope glycoprotein
Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with two T6 Fab
 0.69 98.85 0.95 36-1272 EM 0.00 hetero-3-2-2-mer 25 x NAG HHblits 0.61
7fjn.1.C
Spike glycoprotein,Envelope glycoprotein
Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with two T6 Fab
 0.68 98.85 0.95 36-1272 EM 0.00 hetero-3-2-2-mer 25 x NAG HHblits 0.61
7p40.1.A
Spike glycoprotein
P5C3 is a potent fab neutralizer
 0.67 99.67 0.94 33-1242 EM 0.00 hetero-3-3-3-mer HHblits 0.62
7jji.1.A
Spike glycoprotein
Structure of SARS-CoV-2 3Q-2P full-length prefusion spike trimer (C3 symmetry)
 0.68 98.76 0.95 30-1242 EM 0.00 homo-trimer 3 x NAG, 3 x VCG, 3 x EIC, 45 x NAG-NAG HHblits 0.61
7l7k.1.A
Spike glycoprotein
Cryo-EM structure of protein encoded by vaccine candidate BNT162b2
 0.69 98.76 0.95 30-1242 EM 0.00 homo-trimer HHblits 0.61
7l7k.1.B
Spike glycoprotein
Cryo-EM structure of protein encoded by vaccine candidate BNT162b2
 0.69 98.76 0.95 30-1242 EM 0.00 homo-trimer HHblits 0.61
7d0d.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B
 0.71 98.76 0.95 30-1242 EM 0.00 hetero-3-2-2-mer 26 x NAG, 22 x NAG-NAG HHblits 0.61
7ct5.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with T-ACE2
 0.70 98.76 0.95 30-1242 EM 0.00 hetero-3-3-mer 31 x NAG, 35 x NAG-NAG HHblits 0.61
7c2l.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with 4A8
 0.67 98.76 0.95 30-1242 EM 0.00 hetero-3-3-3-mer 25 x NAG, 6 x NAG-NAG-NAG, 23 x NAG-NAG HHblits 0.61
7c2l.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with 4A8
 0.70 98.76 0.95 30-1242 EM 0.00 hetero-3-3-3-mer 25 x NAG, 6 x NAG-NAG-NAG, 23 x NAG-NAG HHblits 0.61
7c2l.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with 4A8
 0.69 98.76 0.95 30-1242 EM 0.00 hetero-3-3-3-mer 25 x NAG, 6 x NAG-NAG-NAG, 23 x NAG-NAG HHblits 0.61
7ct5.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with T-ACE2
 0.70 98.76 0.95 30-1242 EM 0.00 hetero-3-3-mer 31 x NAG, 35 x NAG-NAG HHblits 0.61
7czt.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G9
 0.71 98.76 0.95 30-1242 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG HHblits 0.61
7d0b.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B
 0.71 98.76 0.95 30-1242 EM 0.00 hetero-3-1-1-mer 27 x NAG, 21 x NAG-NAG HHblits 0.61
7d00.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-1B8
 0.71 98.76 0.95 30-1242 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG HHblits 0.61
7czx.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B9
 0.71 98.76 0.95 30-1242 EM 0.00 hetero-3-3-3-mer 29 x NAG, 19 x NAG-NAG HHblits 0.61
7d0d.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B
 0.71 98.76 0.95 30-1242 EM 0.00 hetero-3-2-2-mer 26 x NAG, 22 x NAG-NAG HHblits 0.61
7czv.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B
 0.71 98.76 0.95 30-1242 EM 0.00 hetero-3-3-3-mer 28 x NAG, 20 x NAG-NAG HHblits 0.61
7ct5.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with T-ACE2
 0.70 98.76 0.95 30-1242 EM 0.00 hetero-3-3-mer 31 x NAG, 35 x NAG-NAG HHblits 0.61
7czw.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G7
 0.71 98.76 0.95 30-1242 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG HHblits 0.61
7czs.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B8_3B
 0.71 98.76 0.95 30-1242 EM 0.00 hetero-3-3-3-mer 28 x NAG, 20 x NAG-NAG HHblits 0.61
7czp.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P2B-1A1
 0.71 98.76 0.95 30-1242 EM 0.00 hetero-3-2-2-mer 27 x NAG, 23 x NAG-NAG HHblits 0.61
7czw.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G7
 0.71 98.76 0.95 30-1242 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG HHblits 0.61
7d0b.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B
 0.70 98.76 0.95 30-1242 EM 0.00 hetero-3-1-1-mer 27 x NAG, 21 x NAG-NAG HHblits 0.61
7czp.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P2B-1A1
 0.71 98.76 0.95 30-1242 EM 0.00 hetero-3-2-2-mer 27 x NAG, 23 x NAG-NAG HHblits 0.61
7d0c.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3A1
 0.70 98.76 0.95 30-1242 EM 0.00 hetero-3-2-2-mer 26 x NAG, 22 x NAG-NAG HHblits 0.61
7d03.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-2G7
 0.70 98.76 0.95 30-1242 EM 0.00 hetero-3-1-1-mer 28 x NAG, 20 x NAG-NAG HHblits 0.61
7czx.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B9
 0.71 98.76 0.95 30-1242 EM 0.00 hetero-3-3-3-mer 29 x NAG, 19 x NAG-NAG HHblits 0.61
7d0d.1.G
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B
 0.71 98.76 0.95 30-1242 EM 0.00 hetero-3-2-2-mer 26 x NAG, 22 x NAG-NAG HHblits 0.61
7d00.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-1B8
 0.71 98.76 0.95 30-1242 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG HHblits 0.61
7czx.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B9
 0.71 98.76 0.95 30-1242 EM 0.00 hetero-3-3-3-mer 29 x NAG, 19 x NAG-NAG HHblits 0.61
7dwx.1.H
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
 0.71 98.76 0.95 30-1242 EM 0.00 hetero-2-2-6-mer 62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAG HHblits 0.61
7dwy.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in the locked conformation
 0.70 98.76 0.95 30-1242 EM 0.00 homo-trimer 47 x NAG, 3 x EIC, 11 x NAG-NAG HHblits 0.61
7dwz.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in the active conformation
 0.71 98.76 0.95 30-1242 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG HHblits 0.61
7dx7.1.A
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and 1 PD bound)
 0.71 98.76 0.95 30-1242 EM 0.00 hetero-3-1-mer 27 x NAG, 27 x NAG-NAG HHblits 0.61
7dwx.1.E
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
 0.71 98.76 0.95 30-1242 EM 0.00 hetero-2-2-6-mer 62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAG HHblits 0.61
7dx7.1.C
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and 1 PD bound)
 0.69 98.76 0.95 30-1242 EM 0.00 hetero-3-1-mer 27 x NAG, 27 x NAG-NAG HHblits 0.61
7dwx.1.F
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
 0.71 98.76 0.95 30-1242 EM 0.00 hetero-2-2-6-mer 62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAG HHblits 0.61
7dx9.1.B
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and 2 PD bound)
 0.71 98.76 0.95 30-1242 EM 0.00 hetero-3-2-mer 28 x NAG, 32 x NAG-NAG HHblits 0.61
7qo7.1.A
Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron Spike B.1.1.529
SARS-CoV-2 S Omicron Spike B.1.1.529
 0.64 97.21 0.95 32-1273 EM 0.00 homo-trimer 14 x NAG, 1 x NAG-NAG-BMA-MAN, 3 x NAG-NAG, 18 x NAG-NAG-BMA, 1 x NAG-NAG-FUC BLAST 0.61
7qo7.1.B
Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron Spike B.1.1.529
SARS-CoV-2 S Omicron Spike B.1.1.529
 0.65 97.21 0.95 32-1273 EM 0.00 homo-trimer 14 x NAG, 1 x NAG-NAG-BMA-MAN, 3 x NAG-NAG, 18 x NAG-NAG-BMA, 1 x NAG-NAG-FUC BLAST 0.61
7qo7.1.C
Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron Spike B.1.1.529
SARS-CoV-2 S Omicron Spike B.1.1.529
 0.65 97.21 0.95 32-1273 EM 0.00 homo-trimer 14 x NAG, 1 x NAG-NAG-BMA-MAN, 3 x NAG-NAG, 18 x NAG-NAG-BMA, 1 x NAG-NAG-FUC BLAST 0.61
7qo9.1.B
Spike glycoprotein,SARS-CoV-2 S Omicron Spike B.1.1.529
SARS-CoV-2 S Omicron Spike B.1.1.529 - RBD and NTD (Local)
 0.30 97.21 0.95 32-1273 EM 0.00 homo-dimer 2 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAG BLAST 0.61
7qo9.1.A
Spike glycoprotein,SARS-CoV-2 S Omicron Spike B.1.1.529
SARS-CoV-2 S Omicron Spike B.1.1.529 - RBD and NTD (Local)
 0.36 97.21 0.95 32-1273 EM 0.00 homo-dimer 2 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAG BLAST 0.61
7dx1.1.A
Spike glycoprotein
S protein of SARS-CoV-2 D614G mutant
 0.69 98.68 0.95 30-1242 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG HHblits 0.61
7dx1.1.B
Spike glycoprotein
S protein of SARS-CoV-2 D614G mutant
 0.69 98.68 0.95 30-1242 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG HHblits 0.61
7dx1.1.C
Spike glycoprotein
S protein of SARS-CoV-2 D614G mutant
 0.69 98.68 0.95 30-1242 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG HHblits 0.61
6xra.1.A
Spike glycoprotein
Distinct conformational states of SARS-CoV-2 spike protein
 0.11 98.60 0.95 30-1242 EM 0.00 homo-trimer 9 x NAG, 6 x NAG-NAG, 6 x NAG-NAG-MAN-MAN, 3 x NAG-NAG-MAN HHblits 0.61
6xr8.1.A
Spike glycoprotein
Distinct conformational states of SARS-CoV-2 spike protein
 0.70 98.60 0.95 30-1242 EM 0.00 homo-trimer 21 x NAG, 21 x NAG-NAG-MAN, 9 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-MAN-MAN HHblits 0.61
7cwn.1.A
Spike glycoprotein
P17-H014 Fab cocktail in complex with SARS-CoV-2 spike protein
 0.69 98.60 0.95 30-1242 EM 0.00 hetero-3-3-3-3-3-mer 16 x NAG, 15 x NAG-NAG HHblits 0.61
7cwm.1.B
Spike glycoprotein
Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed state
 0.69 98.60 0.95 30-1242 EM 0.00 hetero-3-3-3-mer 16 x NAG, 14 x NAG-NAG HHblits 0.61
7cwm.1.C
Spike glycoprotein
Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed state
 0.69 98.60 0.95 30-1242 EM 0.00 hetero-3-3-3-mer 16 x NAG, 14 x NAG-NAG HHblits 0.61
7cwm.1.A
Spike glycoprotein
Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed state
 0.68 98.60 0.95 30-1242 EM 0.00 hetero-3-3-3-mer 16 x NAG, 14 x NAG-NAG HHblits 0.61
7cwu.1.G
Spike glycoprotein
SARS-CoV-2 spike proteins trimer in complex with P17 and FC05 Fabs cocktail
 0.69 98.60 0.95 30-1242 EM 0.00 hetero-3-3-3-3-3-mer 16 x NAG, 15 x NAG-NAG HHblits 0.61
7cwl.1.C
Spike glycoprotein
SARS-CoV-2 spike protein and P17 fab complex with one RBD in close state
 0.69 98.60 0.95 30-1242 EM 0.00 hetero-3-3-3-mer 27 x NAG HHblits 0.61
7cwl.1.A
Spike glycoprotein
SARS-CoV-2 spike protein and P17 fab complex with one RBD in close state
 0.69 98.60 0.95 30-1242 EM 0.00 hetero-3-3-3-mer 27 x NAG HHblits 0.61
7n64.1.B
Spike glycoprotein
SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction)
 0.03 98.60 0.95 30-1242 EM 0.00 hetero-2-1-1-mer 2 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA HHblits 0.61
7n62.1.A
Spike glycoprotein
SARS-CoV-2 Spike (2P) in complex with C12C9 Fab (NTD local reconstruction)
 0.09 98.60 0.95 30-1242 EM 0.00 hetero-1-1-1-mer 5 x NAG HHblits 0.61
7n64.1.A
Spike glycoprotein
SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction)
 0.09 98.60 0.95 30-1242 EM 0.00 hetero-2-1-1-mer 2 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA HHblits 0.61
7fg3.1.A
Spike glycoprotein
Major cryo-EM structure of S protein trimer of SARS-CoV2 with K-874, composite map
 0.54 98.60 0.95 30-1242 EM 0.00 hetero-1-1-mer HHblits 0.61
7fg7.1.A
Spike glycoprotein
Cryo-EM structure of S protein trimer of SARS-CoV2
 0.57 98.60 0.95 30-1242 EM 0.00 monomer HHblits 0.61
7fg2.1.A
Spike glycoprotein
Minor cryo-EM structure of S protein trimer of SARS-CoV2 with K-874A VHH, composite map
 0.57 98.60 0.95 30-1242 EM 0.00 hetero-1-1-mer HHblits 0.61
7krq.1.A
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
 0.70 98.52 0.95 30-1242 EM 3.44 homo-trimer 24 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUC HHblits 0.61
7krr.1.A
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
 0.71 98.52 0.95 30-1242 EM 3.50 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7krr.1.C
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
 0.70 98.52 0.95 30-1242 EM 3.50 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7krs.1.A
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
 0.70 98.52 0.95 30-1242 EM 3.20 homo-trimer 21 x NAG, 30 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-MAN HHblits 0.61
6zwv.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: 3 Closed RBDs
 0.69 98.52 0.95 30-1242 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.61
7x08.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex with 2G1
 0.70 98.43 0.95 30-1242 EM 0.00 hetero-3-3-3-mer 30 x NAG, 3 x EIC, 24 x NAG-NAG HHblits 0.61
7epx.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex with GW01
 0.71 98.43 0.95 30-1242 EM 0.00 hetero-3-2-2-mer 25 x NAG, 23 x NAG-NAG HHblits 0.61
7epx.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex with GW01
 0.71 98.43 0.95 30-1242 EM 0.00 hetero-3-2-2-mer 25 x NAG, 23 x NAG-NAG HHblits 0.61
7epx.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex with GW01
 0.69 98.43 0.95 30-1242 EM 0.00 hetero-3-2-2-mer 25 x NAG, 23 x NAG-NAG HHblits 0.61
7dzw.1.A
Spike glycoprotein
Apo spike protein from SARS-CoV2
 0.61 99.01 0.94 33-1241 EM 0.00 homo-trimer HHblits 0.61
7dzw.1.B
Spike glycoprotein
Apo spike protein from SARS-CoV2
 0.59 99.01 0.94 33-1241 EM 0.00 homo-trimer HHblits 0.61
7dzw.1.C
Spike glycoprotein
Apo spike protein from SARS-CoV2
 0.61 99.01 0.94 33-1241 EM 0.00 homo-trimer HHblits 0.61
7sbp.1.A
Spike glycoprotein
Closed state of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.71 97.94 0.95 29-1242 EM 3.44 homo-trimer 21 x NAG, 6 x NAG-NAG, 27 x NAG-NAG-MAN, 3 x NAG-NAG-FUC HHblits 0.61
7sbq.1.A
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.70 97.94 0.95 29-1242 EM 3.50 homo-trimer 24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MAN HHblits 0.61
7sbq.1.B
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.71 97.94 0.95 29-1242 EM 3.50 homo-trimer 24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MAN HHblits 0.61
7sbq.1.C
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.70 97.94 0.95 29-1242 EM 3.50 homo-trimer 24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MAN HHblits 0.61
7sbr.1.A
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.70 97.94 0.95 29-1242 EM 3.50 homo-trimer 24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MAN HHblits 0.61
7sbr.1.B
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.71 97.94 0.95 29-1242 EM 3.50 homo-trimer 24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MAN HHblits 0.61
7sbr.1.C
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.70 97.94 0.95 29-1242 EM 3.50 homo-trimer 24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MAN HHblits 0.61
7e7d.1.A
Spike glycoprotein,Collagen alpha-1(I) chain
Cryo-EM structure of the SARS-CoV-2 wild-type S-Trimer from a subunit vaccine candidate
 0.71 99.00 0.94 30-1235 EM 3.20 homo-trimer 19 x NAG, 3 x ELA, 32 x NAG-NAG HHblits 0.61
7e7b.1.A
Spike glycoprotein,Collagen alpha-1(I) chain
Cryo-EM structure of the SARS-CoV-2 furin site mutant S-Trimer from a subunit vaccine candidate
 0.69 99.09 0.94 30-1234 EM 0.00 homo-trimer 15 x NAG, 3 x ELA, 3 x VCG, 39 x NAG-NAG HHblits 0.61
7k8s.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)
 0.68 99.33 0.94 30-1232 EM 0.00 hetero-3-3-3-mer 27 x NAG, 15 x NAG-NAG HHblits 0.61
7k8s.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)
 0.68 99.33 0.94 30-1232 EM 0.00 hetero-3-3-3-mer 27 x NAG, 15 x NAG-NAG HHblits 0.61
7k8s.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)
 0.69 99.33 0.94 30-1232 EM 0.00 hetero-3-3-3-mer 27 x NAG, 15 x NAG-NAG HHblits 0.61
7k8t.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2)
 0.69 99.33 0.94 30-1232 EM 0.00 hetero-3-3-3-mer 30 x NAG, 15 x NAG-NAG HHblits 0.61
7k8t.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2)
 0.69 99.33 0.94 30-1232 EM 0.00 hetero-3-3-3-mer 30 x NAG, 15 x NAG-NAG HHblits 0.61
7k8t.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2)
 0.69 99.33 0.94 30-1232 EM 0.00 hetero-3-3-3-mer 30 x NAG, 15 x NAG-NAG HHblits 0.61
7k8x.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1)
 0.67 99.33 0.94 30-1232 EM 3.90 hetero-3-2-2-mer 28 x NAG HHblits 0.61
7k8x.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1)
 0.68 99.33 0.94 30-1232 EM 3.90 hetero-3-2-2-mer 28 x NAG HHblits 0.61
7k8x.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1)
 0.68 99.33 0.94 30-1232 EM 3.90 hetero-3-2-2-mer 28 x NAG HHblits 0.61
7k8y.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2)
 0.67 99.33 0.94 30-1232 EM 4.40 hetero-3-1-1-mer 23 x NAG HHblits 0.61
7k8y.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2)
 0.67 99.33 0.94 30-1232 EM 4.40 hetero-3-1-1-mer 23 x NAG HHblits 0.61
7k8y.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2)
 0.67 99.33 0.94 30-1232 EM 4.40 hetero-3-1-1-mer 23 x NAG HHblits 0.61
7m6i.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24
 0.66 99.33 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 26 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 1 x NAG-NAG-BMA HHblits 0.61
7m6h.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20
 0.58 99.33 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 28 x NAG HHblits 0.61
7m6h.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20
 0.59 99.33 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 28 x NAG HHblits 0.61
7m6i.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24
 0.64 99.33 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 26 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 1 x NAG-NAG-BMA HHblits 0.61
7m6i.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24
 0.64 99.33 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 26 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 1 x NAG-NAG-BMA HHblits 0.61
7m6h.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20
 0.57 99.33 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 28 x NAG HHblits 0.61
6xcm.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 1)
 0.69 99.25 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 30 x NAG, 9 x NAG-NAG, 1 x NAG-FUC, 2 x NAG-NAG-FUC, 1 x NAG-NAG-BMA HHblits 0.61
6xcm.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 1)
 0.69 99.25 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 30 x NAG, 9 x NAG-NAG, 1 x NAG-FUC, 2 x NAG-NAG-FUC, 1 x NAG-NAG-BMA HHblits 0.61
6xcm.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 1)
 0.68 99.25 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 30 x NAG, 9 x NAG-NAG, 1 x NAG-FUC, 2 x NAG-NAG-FUC, 1 x NAG-NAG-BMA HHblits 0.61
7k8z.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135
 0.70 99.25 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 33 x NAG, 13 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x NAG-NAG-BMA-FUC HHblits 0.61
7k8v.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110
 0.64 99.25 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 21 x NAG, 10 x NAG-NAG HHblits 0.61
7k8w.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119
 0.68 99.25 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 34 x NAG, 13 x NAG-NAG HHblits 0.61
7k8w.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119
 0.69 99.25 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 34 x NAG, 13 x NAG-NAG HHblits 0.61
7k8v.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110
 0.63 99.25 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 21 x NAG, 10 x NAG-NAG HHblits 0.61
7k8u.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104
 0.67 99.25 0.94 30-1232 EM 0.00 hetero-3-1-1-mer 2 x NAG, 1 x NAG-NAG HHblits 0.61
7k8u.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104
 0.68 99.25 0.94 30-1232 EM 0.00 hetero-3-1-1-mer 2 x NAG, 1 x NAG-NAG HHblits 0.61
7k8v.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110
 0.65 99.25 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 21 x NAG, 10 x NAG-NAG HHblits 0.61
7k8w.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119
 0.69 99.25 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 34 x NAG, 13 x NAG-NAG HHblits 0.61
7k8z.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135
 0.69 99.25 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 33 x NAG, 13 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x NAG-NAG-BMA-FUC HHblits 0.61
7k8z.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135
 0.69 99.25 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 33 x NAG, 13 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x NAG-NAG-BMA-FUC HHblits 0.61
7k8u.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104
 0.69 99.25 0.94 30-1232 EM 0.00 hetero-3-1-1-mer 2 x NAG, 1 x NAG-NAG HHblits 0.61
6vxx.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein (closed state)
 0.68 100.00 0.94 33-1230 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7jv2.1.C
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains)
 0.00 100.00 0.94 33-1230 EM 0.00 hetero-1-1-1-mer HHblits 0.62
7k43.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment
 0.70 100.00 0.94 33-1230 EM 0.00 hetero-3-3-3-mer 30 x NAG, 18 x NAG-NAG, 3 x NAG-NAG-BMA-FUC HHblits 0.62
7jv4.1.B
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open)
 0.70 100.00 0.94 33-1230 EM 0.00 hetero-3-3-3-mer 36 x NAG, 11 x NAG-NAG HHblits 0.62
7jw0.1.G
Spike glycoprotein
SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment
 0.69 100.00 0.94 33-1230 EM 0.00 hetero-3-3-3-mer 36 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMA HHblits 0.62
7jv4.1.C
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open)
 0.68 100.00 0.94 33-1230 EM 0.00 hetero-3-3-3-mer 36 x NAG, 11 x NAG-NAG HHblits 0.62
7jv4.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open)
 0.71 100.00 0.94 33-1230 EM 0.00 hetero-3-3-3-mer 36 x NAG, 11 x NAG-NAG HHblits 0.62
7mtd.1.B
Spike glycoprotein
Structure of aged SARS-CoV-2 S2P spike at pH 7.4
 0.47 100.00 0.94 33-1230 EM 0.00 homo-trimer 13 x NAG, 14 x NAG-NAG HHblits 0.62
7mtd.1.A
Spike glycoprotein
Structure of aged SARS-CoV-2 S2P spike at pH 7.4
 0.56 100.00 0.94 33-1230 EM 0.00 homo-trimer 13 x NAG, 14 x NAG-NAG HHblits 0.62
7mtd.1.C
Spike glycoprotein
Structure of aged SARS-CoV-2 S2P spike at pH 7.4
 0.53 100.00 0.94 33-1230 EM 0.00 homo-trimer 13 x NAG, 14 x NAG-NAG HHblits 0.62
6vyb.1.A
Spike glycoprotein
SARS-CoV-2 spike ectodomain structure (open state)
 0.68 99.92 0.94 33-1230 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.62
6vyb.1.B
Spike glycoprotein
SARS-CoV-2 spike ectodomain structure (open state)
 0.69 99.92 0.94 33-1230 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.62
6vyb.1.C
Spike glycoprotein
SARS-CoV-2 spike ectodomain structure (open state)
 0.68 99.92 0.94 33-1230 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.62
7qo7.1.A
Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron Spike B.1.1.529
SARS-CoV-2 S Omicron Spike B.1.1.529
 0.64 0.89 96.07 0.95 30-1272 EM 0.00 homo-trimer 14 x NAG, 1 x NAG-NAG-BMA-MAN, 3 x NAG-NAG, 18 x NAG-NAG-BMA, 1 x NAG-NAG-FUC HHblits 0.60
7qo7.1.B
Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron Spike B.1.1.529
SARS-CoV-2 S Omicron Spike B.1.1.529
 0.65 0.88 96.07 0.95 30-1272 EM 0.00 homo-trimer 14 x NAG, 1 x NAG-NAG-BMA-MAN, 3 x NAG-NAG, 18 x NAG-NAG-BMA, 1 x NAG-NAG-FUC HHblits 0.60
✓
 7qo7.1.C
Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron Spike B.1.1.529
SARS-CoV-2 S Omicron Spike B.1.1.529
 0.65 0.88 96.07 0.95 30-1272 EM 0.00 homo-trimer 14 x NAG, 1 x NAG-NAG-BMA-MAN, 3 x NAG-NAG, 18 x NAG-NAG-BMA, 1 x NAG-NAG-FUC HHblits 0.60
7qo9.1.B
Spike glycoprotein,SARS-CoV-2 S Omicron Spike B.1.1.529
SARS-CoV-2 S Omicron Spike B.1.1.529 - RBD and NTD (Local)
 0.30 0.44 96.07 0.95 30-1272 EM 0.00 homo-dimer 2 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAG HHblits 0.60
7qo9.1.A
Spike glycoprotein,SARS-CoV-2 S Omicron Spike B.1.1.529
SARS-CoV-2 S Omicron Spike B.1.1.529 - RBD and NTD (Local)
 0.35 0.44 96.07 0.95 30-1272 EM 0.00 homo-dimer 2 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAG HHblits 0.60
7mte.1.A
Spike glycoprotein
Structure of SARS-CoV-2 S2P spike at pH 7.4 refolded by low-pH treatment
 0.63 99.92 0.94 33-1230 EM 0.00 homo-trimer 14 x NAG, 14 x NAG-NAG HHblits 0.62
7mte.1.B
Spike glycoprotein
Structure of SARS-CoV-2 S2P spike at pH 7.4 refolded by low-pH treatment
 0.54 99.92 0.94 33-1230 EM 0.00 homo-trimer 14 x NAG, 14 x NAG-NAG HHblits 0.62
7mte.1.C
Spike glycoprotein
Structure of SARS-CoV-2 S2P spike at pH 7.4 refolded by low-pH treatment
 0.64 99.92 0.94 33-1230 EM 0.00 homo-trimer 14 x NAG, 14 x NAG-NAG HHblits 0.62
6zb4.1.A
Spike glycoprotein
SARS CoV-2 Spike protein, Closed conformation, C1 symmetry
 0.71 99.17 0.94 30-1232 EM 0.00 homo-trimer 25 x NAG, 3 x EIC, 1 x NAG-NAG HHblits 0.61
7qur.1.C
Spike glycoprotein
SARS-CoV-2 Spike with ethylbenzamide-tri-iodo Siallyllactose, C3 symmetry
 0.66 99.17 0.94 30-1232 EM 0.00 homo-trimer 36 x NAG, 3 x GE9, 3 x SIA, 3 x EIC, 9 x NAG-NAG, 3 x NAG-FUC-NAG-FUC HHblits 0.61
7k8s.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)
 0.69 99.58 0.94 32-1231 EM 0.00 hetero-3-3-3-mer 27 x NAG, 15 x NAG-NAG BLAST 0.62
7k8s.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)
 0.69 99.58 0.94 32-1231 EM 0.00 hetero-3-3-3-mer 27 x NAG, 15 x NAG-NAG BLAST 0.62
7k8s.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)
 0.69 99.58 0.94 32-1231 EM 0.00 hetero-3-3-3-mer 27 x NAG, 15 x NAG-NAG BLAST 0.62
7k8t.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2)
 0.69 99.58 0.94 32-1231 EM 0.00 hetero-3-3-3-mer 30 x NAG, 15 x NAG-NAG BLAST 0.62
7k8t.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2)
 0.69 99.58 0.94 32-1231 EM 0.00 hetero-3-3-3-mer 30 x NAG, 15 x NAG-NAG BLAST 0.62
7k8t.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2)
 0.69 99.58 0.94 32-1231 EM 0.00 hetero-3-3-3-mer 30 x NAG, 15 x NAG-NAG BLAST 0.62
7k8x.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1)
 0.68 99.58 0.94 32-1231 EM 3.90 hetero-3-2-2-mer 28 x NAG BLAST 0.62
7k8x.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1)
 0.69 99.58 0.94 32-1231 EM 3.90 hetero-3-2-2-mer 28 x NAG BLAST 0.62
7k8x.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1)
 0.69 99.58 0.94 32-1231 EM 3.90 hetero-3-2-2-mer 28 x NAG BLAST 0.62
7k8y.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2)
 0.68 99.58 0.94 32-1231 EM 4.40 hetero-3-1-1-mer 23 x NAG BLAST 0.62
7k8y.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2)
 0.68 99.58 0.94 32-1231 EM 4.40 hetero-3-1-1-mer 23 x NAG BLAST 0.62
7k8y.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2)
 0.68 99.58 0.94 32-1231 EM 4.40 hetero-3-1-1-mer 23 x NAG BLAST 0.62
7m6i.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24
 0.66 99.58 0.94 32-1231 EM 0.00 hetero-3-2-2-mer 26 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 1 x NAG-NAG-BMA BLAST 0.62
7m6h.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20
 0.58 99.58 0.94 32-1231 EM 0.00 hetero-3-2-2-mer 28 x NAG BLAST 0.62
7m6h.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20
 0.59 99.58 0.94 32-1231 EM 0.00 hetero-3-2-2-mer 28 x NAG BLAST 0.62
7m6i.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24
 0.64 99.58 0.94 32-1231 EM 0.00 hetero-3-2-2-mer 26 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 1 x NAG-NAG-BMA BLAST 0.62
7m6i.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24
 0.65 99.58 0.94 32-1231 EM 0.00 hetero-3-2-2-mer 26 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 1 x NAG-NAG-BMA BLAST 0.62
7m6h.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20
 0.56 99.58 0.94 32-1231 EM 0.00 hetero-3-2-2-mer 28 x NAG BLAST 0.62
6xcm.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 1)
 0.69 99.50 0.94 32-1231 EM 0.00 hetero-3-2-2-mer 30 x NAG, 9 x NAG-NAG, 1 x NAG-FUC, 2 x NAG-NAG-FUC, 1 x NAG-NAG-BMA BLAST 0.62
6xcm.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 1)
 0.69 99.50 0.94 32-1231 EM 0.00 hetero-3-2-2-mer 30 x NAG, 9 x NAG-NAG, 1 x NAG-FUC, 2 x NAG-NAG-FUC, 1 x NAG-NAG-BMA BLAST 0.62
6xcm.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 1)
 0.68 99.50 0.94 32-1231 EM 0.00 hetero-3-2-2-mer 30 x NAG, 9 x NAG-NAG, 1 x NAG-FUC, 2 x NAG-NAG-FUC, 1 x NAG-NAG-BMA BLAST 0.62
7k8z.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135
 0.70 99.50 0.94 32-1231 EM 0.00 hetero-3-2-2-mer 33 x NAG, 13 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x NAG-NAG-BMA-FUC BLAST 0.62
7k8v.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110
 0.65 99.50 0.94 32-1231 EM 0.00 hetero-3-2-2-mer 21 x NAG, 10 x NAG-NAG BLAST 0.62
7k8w.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119
 0.69 99.50 0.94 32-1231 EM 0.00 hetero-3-2-2-mer 34 x NAG, 13 x NAG-NAG BLAST 0.62
7k8w.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119
 0.69 99.50 0.94 32-1231 EM 0.00 hetero-3-2-2-mer 34 x NAG, 13 x NAG-NAG BLAST 0.62
7k8v.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110
 0.63 99.50 0.94 32-1231 EM 0.00 hetero-3-2-2-mer 21 x NAG, 10 x NAG-NAG BLAST 0.62
7k8u.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104
 0.67 99.50 0.94 32-1231 EM 0.00 hetero-3-1-1-mer 2 x NAG, 1 x NAG-NAG BLAST 0.62
7k8u.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104
 0.69 99.50 0.94 32-1231 EM 0.00 hetero-3-1-1-mer 2 x NAG, 1 x NAG-NAG BLAST 0.62
7k8v.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110
 0.65 99.50 0.94 32-1231 EM 0.00 hetero-3-2-2-mer 21 x NAG, 10 x NAG-NAG BLAST 0.62
7k8w.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119
 0.69 99.50 0.94 32-1231 EM 0.00 hetero-3-2-2-mer 34 x NAG, 13 x NAG-NAG BLAST 0.62
7k8z.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135
 0.69 99.50 0.94 32-1231 EM 0.00 hetero-3-2-2-mer 33 x NAG, 13 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x NAG-NAG-BMA-FUC BLAST 0.62
7k8z.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135
 0.70 99.50 0.94 32-1231 EM 0.00 hetero-3-2-2-mer 33 x NAG, 13 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x NAG-NAG-BMA-FUC BLAST 0.62
7k8u.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104
 0.69 99.50 0.94 32-1231 EM 0.00 hetero-3-1-1-mer 2 x NAG, 1 x NAG-NAG BLAST 0.62
7jji.1.A
Spike glycoprotein
Structure of SARS-CoV-2 3Q-2P full-length prefusion spike trimer (C3 symmetry)
 0.67 99.67 0.94 32-1230 EM 0.00 homo-trimer 3 x NAG, 3 x VCG, 3 x EIC, 45 x NAG-NAG BLAST 0.62
7d0d.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B
 0.71 99.67 0.94 32-1230 EM 0.00 hetero-3-2-2-mer 26 x NAG, 22 x NAG-NAG BLAST 0.62
7ct5.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with T-ACE2
 0.70 99.67 0.94 32-1230 EM 0.00 hetero-3-3-mer 31 x NAG, 35 x NAG-NAG BLAST 0.62
7c2l.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with 4A8
 0.67 99.67 0.94 32-1230 EM 0.00 hetero-3-3-3-mer 25 x NAG, 6 x NAG-NAG-NAG, 23 x NAG-NAG BLAST 0.62
7c2l.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with 4A8
 0.70 99.67 0.94 32-1230 EM 0.00 hetero-3-3-3-mer 25 x NAG, 6 x NAG-NAG-NAG, 23 x NAG-NAG BLAST 0.62
7c2l.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with 4A8
 0.69 99.67 0.94 32-1230 EM 0.00 hetero-3-3-3-mer 25 x NAG, 6 x NAG-NAG-NAG, 23 x NAG-NAG BLAST 0.62
7ct5.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with T-ACE2
 0.70 99.67 0.94 32-1230 EM 0.00 hetero-3-3-mer 31 x NAG, 35 x NAG-NAG BLAST 0.62
7czt.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G9
 0.71 99.67 0.94 32-1230 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG BLAST 0.62
7d0b.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B
 0.71 99.67 0.94 32-1230 EM 0.00 hetero-3-1-1-mer 27 x NAG, 21 x NAG-NAG BLAST 0.62
7d00.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-1B8
 0.71 99.67 0.94 32-1230 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG BLAST 0.62
7czx.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B9
 0.71 99.67 0.94 32-1230 EM 0.00 hetero-3-3-3-mer 29 x NAG, 19 x NAG-NAG BLAST 0.62
7d0d.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B
 0.71 99.67 0.94 32-1230 EM 0.00 hetero-3-2-2-mer 26 x NAG, 22 x NAG-NAG BLAST 0.62
7czv.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B
 0.71 99.67 0.94 32-1230 EM 0.00 hetero-3-3-3-mer 28 x NAG, 20 x NAG-NAG BLAST 0.62
7ct5.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with T-ACE2
 0.70 99.67 0.94 32-1230 EM 0.00 hetero-3-3-mer 31 x NAG, 35 x NAG-NAG BLAST 0.62
7czw.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G7
 0.71 99.67 0.94 32-1230 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG BLAST 0.62
7czs.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B8_3B
 0.70 99.67 0.94 32-1230 EM 0.00 hetero-3-3-3-mer 28 x NAG, 20 x NAG-NAG BLAST 0.62
7czp.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P2B-1A1
 0.71 99.67 0.94 32-1230 EM 0.00 hetero-3-2-2-mer 27 x NAG, 23 x NAG-NAG BLAST 0.62
7czw.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G7
 0.71 99.67 0.94 32-1230 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG BLAST 0.62
7d0b.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B
 0.70 99.67 0.94 32-1230 EM 0.00 hetero-3-1-1-mer 27 x NAG, 21 x NAG-NAG BLAST 0.62
7czp.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P2B-1A1
 0.71 99.67 0.94 32-1230 EM 0.00 hetero-3-2-2-mer 27 x NAG, 23 x NAG-NAG BLAST 0.62
7d0c.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3A1
 0.70 99.67 0.94 32-1230 EM 0.00 hetero-3-2-2-mer 26 x NAG, 22 x NAG-NAG BLAST 0.62
7d03.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-2G7
 0.70 99.67 0.94 32-1230 EM 0.00 hetero-3-1-1-mer 28 x NAG, 20 x NAG-NAG BLAST 0.62
7czx.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B9
 0.71 99.67 0.94 32-1230 EM 0.00 hetero-3-3-3-mer 29 x NAG, 19 x NAG-NAG BLAST 0.62
7d0d.1.G
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B
 0.71 99.67 0.94 32-1230 EM 0.00 hetero-3-2-2-mer 26 x NAG, 22 x NAG-NAG BLAST 0.62
7d00.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-1B8
 0.71 99.67 0.94 32-1230 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG BLAST 0.62
7czx.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B9
 0.71 99.67 0.94 32-1230 EM 0.00 hetero-3-3-3-mer 29 x NAG, 19 x NAG-NAG BLAST 0.62
7dwx.1.H
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
 0.71 99.67 0.94 32-1230 EM 0.00 hetero-2-2-6-mer 62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAG BLAST 0.62
7dwy.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in the locked conformation
 0.70 99.67 0.94 32-1230 EM 0.00 homo-trimer 47 x NAG, 3 x EIC, 11 x NAG-NAG BLAST 0.62
7dwz.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in the active conformation
 0.71 99.67 0.94 32-1230 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG BLAST 0.62
7dx7.1.A
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and 1 PD bound)
 0.71 99.67 0.94 32-1230 EM 0.00 hetero-3-1-mer 27 x NAG, 27 x NAG-NAG BLAST 0.62
7dwx.1.E
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
 0.70 99.67 0.94 32-1230 EM 0.00 hetero-2-2-6-mer 62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAG BLAST 0.62
7dx7.1.C
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and 1 PD bound)
 0.69 99.67 0.94 32-1230 EM 0.00 hetero-3-1-mer 27 x NAG, 27 x NAG-NAG BLAST 0.62
7dwx.1.F
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
 0.71 99.67 0.94 32-1230 EM 0.00 hetero-2-2-6-mer 62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAG BLAST 0.62
7dx9.1.B
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and 2 PD bound)
 0.71 99.67 0.94 32-1230 EM 0.00 hetero-3-2-mer 28 x NAG, 32 x NAG-NAG BLAST 0.62
7l7k.1.A
Spike glycoprotein
Cryo-EM structure of protein encoded by vaccine candidate BNT162b2
 0.69 99.67 0.94 32-1230 EM 0.00 homo-trimer BLAST 0.62
7l7k.1.B
Spike glycoprotein
Cryo-EM structure of protein encoded by vaccine candidate BNT162b2
 0.69 99.67 0.94 32-1230 EM 0.00 homo-trimer BLAST 0.62
7e7b.1.A
Spike glycoprotein,Collagen alpha-1(I) chain
Cryo-EM structure of the SARS-CoV-2 furin site mutant S-Trimer from a subunit vaccine candidate
 0.69 99.42 0.94 32-1232 EM 0.00 homo-trimer 15 x NAG, 3 x ELA, 3 x VCG, 39 x NAG-NAG BLAST 0.61
6x79.1.A
Spike glycoprotein
Prefusion SARS-CoV-2 S ectodomain trimer covalently stabilized in the closed conformation
 0.70 99.83 0.94 33-1230 EM 0.00 homo-trimer 33 x NAG, 9 x NAG-NAG HHblits 0.62
7e7d.1.A
Spike glycoprotein,Collagen alpha-1(I) chain
Cryo-EM structure of the SARS-CoV-2 wild-type S-Trimer from a subunit vaccine candidate
 0.71 99.42 0.94 32-1232 EM 3.20 homo-trimer 19 x NAG, 3 x ELA, 32 x NAG-NAG BLAST 0.61
7kml.1.A
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, three RBDs bound
 0.64 99.25 0.94 30-1230 EM 0.00 hetero-3-3-3-mer 18 x NAG, 21 x NAG-NAG, 6 x NAG-NAG-BMA HHblits 0.61
7kmk.1.B
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, two RBDs bound
 0.63 99.25 0.94 30-1230 EM 0.00 hetero-3-2-2-mer 25 x NAG, 7 x NAG-NAG, 2 x NAG-NAG-BMA HHblits 0.61
7kmk.1.C
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, two RBDs bound
 0.61 99.25 0.94 30-1230 EM 0.00 hetero-3-2-2-mer 25 x NAG, 7 x NAG-NAG, 2 x NAG-NAG-BMA HHblits 0.61
7kmk.1.A
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, two RBDs bound
 0.63 99.25 0.94 30-1230 EM 0.00 hetero-3-2-2-mer 25 x NAG, 7 x NAG-NAG, 2 x NAG-NAG-BMA HHblits 0.61
7kxj.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-"up", asymmetric
 0.61 99.25 0.94 30-1230 EM 0.00 hetero-3-3-3-mer 7 x NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG HHblits 0.61
7kxj.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-"up", asymmetric
 0.61 99.25 0.94 30-1230 EM 0.00 hetero-3-3-3-mer 7 x NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG HHblits 0.61
7kxj.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-"up", asymmetric
 0.60 99.25 0.94 30-1230 EM 0.00 hetero-3-3-3-mer 7 x NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG HHblits 0.61
7kxk.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation
 0.61 99.25 0.94 30-1230 EM 0.00 hetero-3-3-3-mer 16 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMA HHblits 0.61
7kxk.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation
 0.61 99.25 0.94 30-1230 EM 0.00 hetero-3-3-3-mer 16 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMA HHblits 0.61
7kxk.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation
 0.63 99.25 0.94 30-1230 EM 0.00 hetero-3-3-3-mer 16 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMA HHblits 0.61
7dzw.1.A
Spike glycoprotein
Apo spike protein from SARS-CoV2
 0.61 99.75 0.94 33-1230 EM 0.00 homo-trimer BLAST 0.62
7dzw.1.B
Spike glycoprotein
Apo spike protein from SARS-CoV2
 0.59 99.75 0.94 33-1230 EM 0.00 homo-trimer BLAST 0.62
7dzw.1.C
Spike glycoprotein
Apo spike protein from SARS-CoV2
 0.61 99.75 0.94 33-1230 EM 0.00 homo-trimer BLAST 0.62
7k9j.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2H04 (three down conformation)
 0.68 99.25 0.94 30-1232 EM 0.00 hetero-3-3-3-mer 3 x NAG, 12 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-NAG-BMA-FUC, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MAN HHblits 0.61
7k9h.1.B
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation)
 0.68 99.25 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 3 x NAG, 14 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MAN HHblits 0.61
7k9h.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation)
 0.68 99.25 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 3 x NAG, 14 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MAN HHblits 0.61
7k9h.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation)
 0.69 99.25 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 3 x NAG, 14 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MAN HHblits 0.61
7dx1.1.A
Spike glycoprotein
S protein of SARS-CoV-2 D614G mutant
 0.69 99.58 0.94 32-1230 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG BLAST 0.62
7dx1.1.B
Spike glycoprotein
S protein of SARS-CoV-2 D614G mutant
 0.69 99.58 0.94 32-1230 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG BLAST 0.62
7dx1.1.C
Spike glycoprotein
S protein of SARS-CoV-2 D614G mutant
 0.69 99.58 0.94 32-1230 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG BLAST 0.62
7sbs.1.A
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Gamma variant spike protein
 0.69 97.69 0.95 31-1242 EM 3.50 homo-trimer 29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7sbs.1.B
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Gamma variant spike protein
 0.70 97.69 0.95 31-1242 EM 3.50 homo-trimer 29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7sbs.1.C
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Gamma variant spike protein
 0.69 97.69 0.95 31-1242 EM 3.50 homo-trimer 29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7sbt.1.A
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Gamma variant spike protein
 0.69 97.69 0.95 31-1242 EM 3.50 homo-trimer 28 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-FUC, 9 x NAG-NAG-MAN HHblits 0.61
7sbt.1.B
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Gamma variant spike protein
 0.69 97.69 0.95 31-1242 EM 3.50 homo-trimer 28 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-FUC, 9 x NAG-NAG-MAN HHblits 0.61
7sbt.1.C
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Gamma variant spike protein
 0.69 97.69 0.95 31-1242 EM 3.50 homo-trimer 28 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-FUC, 9 x NAG-NAG-MAN HHblits 0.61
6zb4.1.A
Spike glycoprotein
SARS CoV-2 Spike protein, Closed conformation, C1 symmetry
 0.71 99.42 0.94 32-1231 EM 0.00 homo-trimer 25 x NAG, 3 x EIC, 1 x NAG-NAG BLAST 0.61
7qur.1.C
Spike glycoprotein
SARS-CoV-2 Spike with ethylbenzamide-tri-iodo Siallyllactose, C3 symmetry
 0.67 99.42 0.94 32-1231 EM 0.00 homo-trimer 36 x NAG, 3 x GE9, 3 x SIA, 3 x EIC, 9 x NAG-NAG, 3 x NAG-FUC-NAG-FUC BLAST 0.61
7sbk.1.A
Spike glycoprotein
Closed state of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.70 97.85 0.95 30-1242 EM 3.44 homo-trimer 21 x NAG, 27 x NAG-NAG-MAN, 3 x NAG-NAG, 3 x NAG-NAG-FUC HHblits 0.61
7sbl.1.A
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.70 97.85 0.95 30-1242 EM 3.44 homo-trimer 25 x NAG, 10 x NAG-NAG-MAN, 16 x NAG-NAG, 3 x NAG-NAG-FUC HHblits 0.61
7sbl.1.B
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.71 97.85 0.95 30-1242 EM 3.44 homo-trimer 25 x NAG, 10 x NAG-NAG-MAN, 16 x NAG-NAG, 3 x NAG-NAG-FUC HHblits 0.61
7sbl.1.C
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.70 97.85 0.95 30-1242 EM 3.44 homo-trimer 25 x NAG, 10 x NAG-NAG-MAN, 16 x NAG-NAG, 3 x NAG-NAG-FUC HHblits 0.61
7sbo.1.A
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.70 97.85 0.95 30-1242 EM 3.44 homo-trimer 24 x NAG, 10 x NAG-NAG-MAN, 17 x NAG-NAG, 3 x NAG-NAG-FUC HHblits 0.61
7sbo.1.B
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.70 97.85 0.95 30-1242 EM 3.44 homo-trimer 24 x NAG, 10 x NAG-NAG-MAN, 17 x NAG-NAG, 3 x NAG-NAG-FUC HHblits 0.61
7sbo.1.C
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.70 97.85 0.95 30-1242 EM 3.44 homo-trimer 24 x NAG, 10 x NAG-NAG-MAN, 17 x NAG-NAG, 3 x NAG-NAG-FUC HHblits 0.61
7k9j.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2H04 (three down conformation)
 0.68 99.75 0.93 32-1231 EM 0.00 hetero-3-3-3-mer 3 x NAG, 12 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-NAG-BMA-FUC, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MAN BLAST 0.62
7k9h.1.B
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation)
 0.69 99.75 0.93 32-1231 EM 0.00 hetero-3-2-2-mer 3 x NAG, 14 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MAN BLAST 0.62
7k9h.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation)
 0.69 99.75 0.93 32-1231 EM 0.00 hetero-3-2-2-mer 3 x NAG, 14 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MAN BLAST 0.62
7k9h.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation)
 0.69 99.75 0.93 32-1231 EM 0.00 hetero-3-2-2-mer 3 x NAG, 14 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MAN BLAST 0.62
6xs6.1.A
Spike glycoprotein
SARS-CoV-2 Spike D614G variant, minus RBD
 0.49 99.17 0.94 30-1232 EM 0.00 homo-trimer HHblits 0.61
7tgy.1.A
Spike glycoprotein
Prototypic SARS-CoV-2 G614 spike (closed form)
 0.68 99.67 0.94 33-1230 EM 0.00 homo-trimer 24 x NAG, 9 x NAG-NAG HHblits 0.62
7tgx.1.B
Spike glycoprotein
Prototypic SARS-CoV-2 G614 spike (open form)
 0.68 99.67 0.94 33-1230 EM 0.00 homo-trimer 23 x NAG, 1 x MAN, 4 x NAG-MAN HHblits 0.62
7tgx.1.C
Spike glycoprotein
Prototypic SARS-CoV-2 G614 spike (open form)
 0.67 99.67 0.94 33-1230 EM 0.00 homo-trimer 23 x NAG, 1 x MAN, 4 x NAG-MAN HHblits 0.62
7tgx.1.A
Spike glycoprotein
Prototypic SARS-CoV-2 G614 spike (open form)
 0.68 99.67 0.94 33-1230 EM 0.00 homo-trimer 23 x NAG, 1 x MAN, 4 x NAG-MAN HHblits 0.62
7kml.1.A
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, three RBDs bound
 0.64 99.42 0.94 32-1230 EM 0.00 hetero-3-3-3-mer 18 x NAG, 21 x NAG-NAG, 6 x NAG-NAG-BMA BLAST 0.62
7kmk.1.B
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, two RBDs bound
 0.63 99.42 0.94 32-1230 EM 0.00 hetero-3-2-2-mer 25 x NAG, 7 x NAG-NAG, 2 x NAG-NAG-BMA BLAST 0.62
7kmk.1.C
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, two RBDs bound
 0.62 99.42 0.94 32-1230 EM 0.00 hetero-3-2-2-mer 25 x NAG, 7 x NAG-NAG, 2 x NAG-NAG-BMA BLAST 0.62
7kmk.1.A
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, two RBDs bound
 0.64 99.42 0.94 32-1230 EM 0.00 hetero-3-2-2-mer 25 x NAG, 7 x NAG-NAG, 2 x NAG-NAG-BMA BLAST 0.62
7kxj.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-"up", asymmetric
 0.60 99.42 0.94 32-1230 EM 0.00 hetero-3-3-3-mer 7 x NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG BLAST 0.62
7kxj.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-"up", asymmetric
 0.60 99.42 0.94 32-1230 EM 0.00 hetero-3-3-3-mer 7 x NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG BLAST 0.62
7kxj.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-"up", asymmetric
 0.60 99.42 0.94 32-1230 EM 0.00 hetero-3-3-3-mer 7 x NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG BLAST 0.62
7kxk.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation
 0.62 99.42 0.94 32-1230 EM 0.00 hetero-3-3-3-mer 16 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMA BLAST 0.62
7kxk.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation
 0.61 99.42 0.94 32-1230 EM 0.00 hetero-3-3-3-mer 16 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMA BLAST 0.62
7kxk.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation
 0.63 99.42 0.94 32-1230 EM 0.00 hetero-3-3-3-mer 16 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMA BLAST 0.62
7cwn.1.A
Spike glycoprotein
P17-H014 Fab cocktail in complex with SARS-CoV-2 spike protein
 0.68 99.50 0.94 32-1230 EM 0.00 hetero-3-3-3-3-3-mer 16 x NAG, 15 x NAG-NAG BLAST 0.61
7cwm.1.B
Spike glycoprotein
Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed state
 0.68 99.50 0.94 32-1230 EM 0.00 hetero-3-3-3-mer 16 x NAG, 14 x NAG-NAG BLAST 0.61
7cwm.1.C
Spike glycoprotein
Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed state
 0.68 99.50 0.94 32-1230 EM 0.00 hetero-3-3-3-mer 16 x NAG, 14 x NAG-NAG BLAST 0.61
7cwm.1.A
Spike glycoprotein
Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed state
 0.68 99.50 0.94 32-1230 EM 0.00 hetero-3-3-3-mer 16 x NAG, 14 x NAG-NAG BLAST 0.61
7cwu.1.G
Spike glycoprotein
SARS-CoV-2 spike proteins trimer in complex with P17 and FC05 Fabs cocktail
 0.69 99.50 0.94 32-1230 EM 0.00 hetero-3-3-3-3-3-mer 16 x NAG, 15 x NAG-NAG BLAST 0.61
7cwl.1.C
Spike glycoprotein
SARS-CoV-2 spike protein and P17 fab complex with one RBD in close state
 0.68 99.50 0.94 32-1230 EM 0.00 hetero-3-3-3-mer 27 x NAG BLAST 0.61
7cwl.1.A
Spike glycoprotein
SARS-CoV-2 spike protein and P17 fab complex with one RBD in close state
 0.68 99.50 0.94 32-1230 EM 0.00 hetero-3-3-3-mer 27 x NAG BLAST 0.61
7n64.1.B
Spike glycoprotein
SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction)
 0.03 99.50 0.94 32-1230 EM 0.00 hetero-2-1-1-mer 2 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA BLAST 0.61
7n62.1.A
Spike glycoprotein
SARS-CoV-2 Spike (2P) in complex with C12C9 Fab (NTD local reconstruction)
 0.09 99.50 0.94 32-1230 EM 0.00 hetero-1-1-1-mer 5 x NAG BLAST 0.61
7n64.1.A
Spike glycoprotein
SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction)
 0.09 99.50 0.94 32-1230 EM 0.00 hetero-2-1-1-mer 2 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA BLAST 0.61
7fg3.1.A
Spike glycoprotein
Major cryo-EM structure of S protein trimer of SARS-CoV2 with K-874, composite map
 0.53 99.50 0.94 32-1230 EM 0.00 hetero-1-1-mer BLAST 0.61
7fg7.1.A
Spike glycoprotein
Cryo-EM structure of S protein trimer of SARS-CoV2
 0.57 99.50 0.94 32-1230 EM 0.00 monomer BLAST 0.61
7fg2.1.A
Spike glycoprotein
Minor cryo-EM structure of S protein trimer of SARS-CoV2 with K-874A VHH, composite map
 0.57 99.50 0.94 32-1230 EM 0.00 hetero-1-1-mer BLAST 0.61
6xra.1.A
Spike glycoprotein
Distinct conformational states of SARS-CoV-2 spike protein
 0.11 99.50 0.94 32-1230 EM 0.00 homo-trimer 9 x NAG, 6 x NAG-NAG, 6 x NAG-NAG-MAN-MAN, 3 x NAG-NAG-MAN BLAST 0.61
6xr8.1.A
Spike glycoprotein
Distinct conformational states of SARS-CoV-2 spike protein
 0.70 99.50 0.94 32-1230 EM 0.00 homo-trimer 21 x NAG, 21 x NAG-NAG-MAN, 9 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-MAN-MAN BLAST 0.61
7e5r.1.G
Spike glycoprotein
SARS-CoV-2 S trimer with three-antibody cocktail complex
 0.65 99.50 0.94 30-1227 EM 3.60 hetero-3-3-3-3-3-3-… 15 x NAG-NAG HHblits 0.62
7e5s.1.B
Spike glycoprotein
SARS-CoV-2 S trimer with four-antibody cocktail complex
 0.62 99.50 0.94 30-1227 EM 3.60 hetero-3-2-2-2-2-3-… 12 x NAG-NAG HHblits 0.62
7e5s.1.A
Spike glycoprotein
SARS-CoV-2 S trimer with four-antibody cocktail complex
 0.63 99.50 0.94 30-1227 EM 3.60 hetero-3-2-2-2-2-3-… 12 x NAG-NAG HHblits 0.62
7e5s.1.C
Spike glycoprotein
SARS-CoV-2 S trimer with four-antibody cocktail complex
 0.63 99.50 0.94 30-1227 EM 3.60 hetero-3-2-2-2-2-3-… 12 x NAG-NAG HHblits 0.62
7ej5.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-45
 0.65 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 24 x NAG, 24 x NAG-NAG HHblits 0.62
7ej4.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25
 0.63 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 21 x NAG, 27 x NAG-NAG HHblits 0.62
7ej4.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25
 0.64 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 21 x NAG, 27 x NAG-NAG HHblits 0.62
7ej4.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25
 0.64 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 21 x NAG, 27 x NAG-NAG HHblits 0.62
7ej5.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-45
 0.65 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 24 x NAG, 24 x NAG-NAG HHblits 0.62
7ej5.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-45
 0.64 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 24 x NAG, 24 x NAG-NAG HHblits 0.62
7akd.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fragment
 0.65 99.50 0.94 30-1227 EM 0.00 hetero-3-2-2-mer 25 x NAG, 3 x FUC, 2 x MAN, 10 x NAG-NAG, 3 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x MAN-MAN HHblits 0.62
7akd.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fragment
 0.64 99.50 0.94 30-1227 EM 0.00 hetero-3-2-2-mer 25 x NAG, 3 x FUC, 2 x MAN, 10 x NAG-NAG, 3 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x MAN-MAN HHblits 0.62
7akd.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fragment
 0.64 99.50 0.94 30-1227 EM 0.00 hetero-3-2-2-mer 25 x NAG, 3 x FUC, 2 x MAN, 10 x NAG-NAG, 3 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x MAN-MAN HHblits 0.62
7oan.1.A
Spike glycoprotein
Nanobody C5 bound to Spike
 0.72 99.50 0.94 30-1227 EM 3.00 hetero-3-3-mer 36 x NAG, 15 x NAG-NAG HHblits 0.62
7ddd.1.B
Spike glycoprotein
SARS-Cov2 S protein at close state
 0.66 99.50 0.94 30-1227 EM 0.00 homo-trimer HHblits 0.62
7ddn.1.C
Spike glycoprotein
SARS-Cov2 S protein at open state
 0.66 99.50 0.94 30-1227 EM 0.00 homo-trimer HHblits 0.62
7ddn.1.A
Spike glycoprotein
SARS-Cov2 S protein at open state
 0.66 99.50 0.94 30-1227 EM 0.00 homo-trimer HHblits 0.62
7dd8.1.C
Spike glycoprotein
S-3C1-F1 structure, one RBD is up and two RBDs are down, the up RBD binds with a 3C1 fab
 0.61 99.50 0.94 30-1227 EM 0.00 hetero-1-1-3-mer HHblits 0.62
7dd8.1.D
Spike glycoprotein
S-3C1-F1 structure, one RBD is up and two RBDs are down, the up RBD binds with a 3C1 fab
 0.61 99.50 0.94 30-1227 EM 0.00 hetero-1-1-3-mer HHblits 0.62
7ddn.1.B
Spike glycoprotein
SARS-Cov2 S protein at open state
 0.65 99.50 0.94 30-1227 EM 0.00 homo-trimer HHblits 0.62
7dk3.1.C
Spike glycoprotein
SARS-CoV-2 S trimer, S-open
 0.66 99.50 0.94 30-1227 EM 0.00 homo-trimer HHblits 0.62
7dk3.1.B
Spike glycoprotein
SARS-CoV-2 S trimer, S-open
 0.67 99.50 0.94 30-1227 EM 0.00 homo-trimer HHblits 0.62
7dk3.1.A
Spike glycoprotein
SARS-CoV-2 S trimer, S-open
 0.67 99.50 0.94 30-1227 EM 0.00 homo-trimer HHblits 0.62
7df4.1.D
Spike glycoprotein
SARS-CoV-2 S-ACE2 complex
 0.67 99.50 0.94 30-1227 EM 0.00 hetero-1-3-mer 36 x NAG, 18 x NAG-NAG HHblits 0.62
7df4.1.C
Spike glycoprotein
SARS-CoV-2 S-ACE2 complex
 0.67 99.50 0.94 30-1227 EM 0.00 hetero-1-3-mer 36 x NAG, 18 x NAG-NAG HHblits 0.62
7df4.1.B
Spike glycoprotein
SARS-CoV-2 S-ACE2 complex
 0.66 99.50 0.94 30-1227 EM 0.00 hetero-1-3-mer 36 x NAG, 18 x NAG-NAG HHblits 0.62
7dd2.1.B
Spike glycoprotein
S-3C1-F2 structure, two RBDs are up and one RBD is down, the two up RBD bind with a 3C1 fab.
 0.63 99.50 0.94 30-1227 EM 0.00 hetero-3-2-2-mer HHblits 0.62
7dk5.1.E
Spike glycoprotein
S-2H2-F1 structure, one RBD is up and two RBDs are down, only up RBD binds with a 2H2 Fab
 0.63 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer HHblits 0.62
7dk5.1.B
Spike glycoprotein
S-2H2-F1 structure, one RBD is up and two RBDs are down, only up RBD binds with a 2H2 Fab
 0.63 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer HHblits 0.62
7dd2.1.A
Spike glycoprotein
S-3C1-F2 structure, two RBDs are up and one RBD is down, the two up RBD bind with a 3C1 fab.
 0.63 99.50 0.94 30-1227 EM 0.00 hetero-3-2-2-mer HHblits 0.62
7dk6.1.C
Spike glycoprotein
S-2H2-F2 structure, two RBDs are up and one RBD is down, each up RBD binds with a 2H2 Fab.
 0.68 99.50 0.94 30-1227 EM 0.00 hetero-3-2-2-mer HHblits 0.62
7dk7.1.I
Spike glycoprotein
S-2H2-F3b structure, three RBDs are up and each RBD binds with a 2H2 Fab.
 0.61 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer HHblits 0.62
7dk7.1.D
Spike glycoprotein
S-2H2-F3b structure, three RBDs are up and each RBD binds with a 2H2 Fab.
 0.65 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer HHblits 0.62
7dk4.1.D
Spike glycoprotein
S-2H2-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 2H2 Fab.
 0.68 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer HHblits 0.62
7dcc.1.D
Spike glycoprotein
S-3C1-F3b structure, all the three RBDs are in the up conformation and each of them associates with a 3C1 Fab
 0.65 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer HHblits 0.62
7dk6.1.A
Spike glycoprotein
S-2H2-F2 structure, two RBDs are up and one RBD is down, each up RBD binds with a 2H2 Fab.
 0.68 99.50 0.94 30-1227 EM 0.00 hetero-3-2-2-mer HHblits 0.62
7dcx.1.H
Spike glycoprotein
S-3C1-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 3C1 fab.
 0.64 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer HHblits 0.62
7dk5.1.A
Spike glycoprotein
S-2H2-F1 structure, one RBD is up and two RBDs are down, only up RBD binds with a 2H2 Fab
 0.62 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer HHblits 0.62
7dk4.1.C
Spike glycoprotein
S-2H2-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 2H2 Fab.
 0.68 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer HHblits 0.62
7dcc.1.H
Spike glycoprotein
S-3C1-F3b structure, all the three RBDs are in the up conformation and each of them associates with a 3C1 Fab
 0.65 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer HHblits 0.62
7dcx.1.C
Spike glycoprotein
S-3C1-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 3C1 fab.
 0.62 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer HHblits 0.62
7dd2.1.E
Spike glycoprotein
S-3C1-F2 structure, two RBDs are up and one RBD is down, the two up RBD bind with a 3C1 fab.
 0.63 99.50 0.94 30-1227 EM 0.00 hetero-3-2-2-mer HHblits 0.62
7dk6.1.B
Spike glycoprotein
S-2H2-F2 structure, two RBDs are up and one RBD is down, each up RBD binds with a 2H2 Fab.
 0.67 99.50 0.94 30-1227 EM 0.00 hetero-3-2-2-mer HHblits 0.62
7dk7.1.C
Spike glycoprotein
S-2H2-F3b structure, three RBDs are up and each RBD binds with a 2H2 Fab.
 0.65 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer HHblits 0.62
7dcc.1.G
Spike glycoprotein
S-3C1-F3b structure, all the three RBDs are in the up conformation and each of them associates with a 3C1 Fab
 0.65 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer HHblits 0.62
7dcx.1.I
Spike glycoprotein
S-3C1-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 3C1 fab.
 0.63 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer HHblits 0.62
7dk4.1.E
Spike glycoprotein
S-2H2-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 2H2 Fab.
 0.69 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer HHblits 0.62
7byr.1.A
Spike glycoprotein
BD23-Fab in complex with the S ectodomain trimer
 0.68 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 32 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-BMA HHblits 0.62
7byr.1.B
Spike glycoprotein
BD23-Fab in complex with the S ectodomain trimer
 0.69 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 32 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-BMA HHblits 0.62
7byr.1.C
Spike glycoprotein
BD23-Fab in complex with the S ectodomain trimer
 0.69 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 32 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-BMA HHblits 0.62
7kni.1.B
Spike glycoprotein
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.63 99.50 0.94 30-1227 EM 0.00 hetero-3-3-mer 56 x NAG, 6 x NAG-NAG HHblits 0.62
6zxn.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1)
 0.72 99.50 0.94 30-1227 EM 0.00 hetero-3-3-mer 39 x NAG, 12 x NAG-NAG HHblits 0.62
7a29.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up conformation
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-3-mer 45 x NAG, 8 x NAG-NAG HHblits 0.62
7a29.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up conformation
 0.72 99.50 0.94 30-1227 EM 0.00 hetero-3-3-mer 45 x NAG, 8 x NAG-NAG HHblits 0.62
7a29.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up conformation
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-3-mer 45 x NAG, 8 x NAG-NAG HHblits 0.62
6vsb.1.B
Spike glycoprotein
Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up
 0.70 99.50 0.94 30-1227 EM 0.00 homo-trimer 27 x NAG, 17 x NAG-NAG HHblits 0.62
6zxn.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1)
 0.71 99.50 0.94 30-1227 EM 0.00 hetero-3-3-mer 39 x NAG, 12 x NAG-NAG HHblits 0.62
6xey.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4
 0.67 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 36 x NAG, 7 x NAG-NAG, 3 x NAG-NAG-BMA, 2 x NAG-BMA HHblits 0.62
6vsb.1.A
Spike glycoprotein
Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up
 0.69 99.50 0.94 30-1227 EM 0.00 homo-trimer 27 x NAG, 17 x NAG-NAG HHblits 0.62
6vsb.1.C
Spike glycoprotein
Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up
 0.69 99.50 0.94 30-1227 EM 0.00 homo-trimer 27 x NAG, 17 x NAG-NAG HHblits 0.62
6zow.1.A
Spike glycoprotein
SARS-CoV-2 spike in prefusion state
 0.52 99.50 0.94 30-1227 EM 0.00 homo-tetramer 18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMA HHblits 0.62
6zp5.1.B
Spike glycoprotein
SARS-CoV-2 spike in prefusion state (flexibility analysis, 1-up closed conformation)
 0.68 99.50 0.94 30-1227 EM 0.00 homo-trimer 18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMA HHblits 0.62
6zp5.1.A
Spike glycoprotein
SARS-CoV-2 spike in prefusion state (flexibility analysis, 1-up closed conformation)
 0.68 99.50 0.94 30-1227 EM 0.00 homo-trimer 18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMA HHblits 0.62
6zow.1.C
Spike glycoprotein
SARS-CoV-2 spike in prefusion state
 0.64 99.50 0.94 30-1227 EM 0.00 homo-tetramer 18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMA HHblits 0.62
7ks9.1.E
Spike glycoprotein
Cryo-EM structure of prefusion SARS-CoV-2 spike glycoprotein in complex with 910-30 Fab
 0.68 99.50 0.94 30-1227 EM 0.00 hetero-1-1-3-mer 35 x NAG, 12 x NAG-NAG HHblits 0.62
7ks9.1.C
Spike glycoprotein
Cryo-EM structure of prefusion SARS-CoV-2 spike glycoprotein in complex with 910-30 Fab
 0.68 99.50 0.94 30-1227 EM 0.00 hetero-1-1-3-mer 35 x NAG, 12 x NAG-NAG HHblits 0.62
7ks9.1.D
Spike glycoprotein
Cryo-EM structure of prefusion SARS-CoV-2 spike glycoprotein in complex with 910-30 Fab
 0.69 99.50 0.94 30-1227 EM 0.00 hetero-1-1-3-mer 35 x NAG, 12 x NAG-NAG HHblits 0.62
7ljr.1.B
Spike glycoprotein
SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab
 0.64 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer HHblits 0.62
7ljr.1.A
Spike glycoprotein
SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab
 0.66 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer HHblits 0.62
7ljr.1.C
Spike glycoprotein
SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab
 0.65 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer HHblits 0.62
7l57.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15
 0.61 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 31 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-NAG, 1 x NAG-NAG-BMA-NAG HHblits 0.62
7kkk.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6
 0.69 99.50 0.94 30-1227 EM 0.00 hetero-3-3-mer 30 x NAG, 12 x NAG-NAG HHblits 0.62
7l57.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15
 0.60 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 31 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-NAG, 1 x NAG-NAG-BMA-NAG HHblits 0.62
7l56.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-43
 0.69 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 31 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-NAG-GAL-MAN-MAN HHblits 0.62
7l58.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4
 0.61 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 33 x NAG, 4 x NAG-NAG HHblits 0.62
7kkl.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing nanobody mNb6
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-3-mer 27 x NAG, 18 x NAG-NAG HHblits 0.62
7l57.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15
 0.61 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 31 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-NAG, 1 x NAG-NAG-BMA-NAG HHblits 0.62
7l58.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4
 0.64 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 33 x NAG, 4 x NAG-NAG HHblits 0.62
7l58.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4
 0.64 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 33 x NAG, 4 x NAG-NAG HHblits 0.62
7b18.1.A
Spike glycoprotein
SARS-CoV-spike bound to two neutralising nanobodies
 0.69 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 42 x NAG, 1 x NAG-NAG HHblits 0.62
7b18.1.B
Spike glycoprotein
SARS-CoV-spike bound to two neutralising nanobodies
 0.71 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 42 x NAG, 1 x NAG-NAG HHblits 0.62
7b18.1.C
Spike glycoprotein
SARS-CoV-spike bound to two neutralising nanobodies
 0.71 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 42 x NAG, 1 x NAG-NAG HHblits 0.62
6zp7.1.C
Spike glycoprotein
SARS-CoV-2 spike in prefusion state (flexibility analysis, 1-up open conformation)
 0.64 99.50 0.94 30-1227 EM 0.00 homo-trimer 18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMA HHblits 0.62
7l2d.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.63 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 34 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-BMA HHblits 0.62
7l2d.1.D
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.65 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 34 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-BMA HHblits 0.62
7l2e.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 4-18 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.64 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 30 x NAG, 24 x NAG-NAG HHblits 0.62
7l2f.1.B
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.65 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 36 x NAG, 16 x NAG-NAG, 2 x NAG-NAG-BMA HHblits 0.62
7l2f.1.C
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.65 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 36 x NAG, 16 x NAG-NAG, 2 x NAG-NAG-BMA HHblits 0.62
7l2d.1.E
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.66 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 34 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-BMA HHblits 0.62
7l2f.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.64 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 36 x NAG, 16 x NAG-NAG, 2 x NAG-NAG-BMA HHblits 0.62
7ksg.1.C
Spike glycoprotein
SARS-CoV-2 spike in complex with nanobodies E
 0.69 99.50 0.94 30-1227 EM 0.00 hetero-3-3-mer 51 x NAG HHblits 0.62
7ksg.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with nanobodies E
 0.68 99.50 0.94 30-1227 EM 0.00 hetero-3-3-mer 51 x NAG HHblits 0.62
7ksg.1.B
Spike glycoprotein
SARS-CoV-2 spike in complex with nanobodies E
 0.69 99.50 0.94 30-1227 EM 0.00 hetero-3-3-mer 51 x NAG HHblits 0.62
7rw2.1.C
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 5-7 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.64 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 48 x NAG, 6 x NAG-NAG HHblits 0.62
7ls9.1.D
Spike glycoprotein
Cryo-EM structure of neutralizing antibody 1-57 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.65 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 30 x NAG, 3 x NAG-NAG-BMA, 18 x NAG-NAG HHblits 0.62
7lss.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7
 0.53 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 30 x NAG, 6 x NAG-NAG HHblits 0.62
7lss.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7
 0.69 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 30 x NAG, 6 x NAG-NAG HHblits 0.62
7lss.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7
 0.53 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 30 x NAG, 6 x NAG-NAG HHblits 0.62
7n5h.1.B
Spike glycoprotein
Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.69 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 9 x NAG, 16 x NAG-NAG HHblits 0.62
7n5h.1.C
Spike glycoprotein
Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 9 x NAG, 16 x NAG-NAG HHblits 0.62
7n5h.1.A
Spike glycoprotein
Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.69 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 9 x NAG, 16 x NAG-NAG HHblits 0.62
7kne.1.C
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5
 0.62 99.50 0.94 30-1227 EM 0.00 hetero-3-1-mer 44 x NAG, 6 x NAG-NAG HHblits 0.62
7kms.1.B
Spike glycoprotein
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.66 99.50 0.94 30-1227 EM 0.00 hetero-3-3-mer 55 x NAG, 8 x NAG-NAG HHblits 0.62
7knh.1.B
Spike glycoprotein
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.63 99.50 0.94 30-1227 EM 0.00 hetero-3-2-mer 48 x NAG, 4 x NAG-NAG HHblits 0.62
7kne.1.B
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5
 0.63 99.50 0.94 30-1227 EM 0.00 hetero-3-1-mer 44 x NAG, 6 x NAG-NAG HHblits 0.62
7kms.1.D
Spike glycoprotein
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.67 99.50 0.94 30-1227 EM 0.00 hetero-3-3-mer 55 x NAG, 8 x NAG-NAG HHblits 0.62
7knh.1.D
Spike glycoprotein
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.63 99.50 0.94 30-1227 EM 0.00 hetero-3-2-mer 48 x NAG, 4 x NAG-NAG HHblits 0.62
6zxn.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1)
 0.72 99.50 0.94 30-1227 EM 0.00 hetero-3-3-mer 39 x NAG, 12 x NAG-NAG HHblits 0.62
7knh.1.A
Spike glycoprotein
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.65 99.50 0.94 30-1227 EM 0.00 hetero-3-2-mer 48 x NAG, 4 x NAG-NAG HHblits 0.62
7knb.1.A
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.65 99.50 0.94 30-1227 EM 0.00 hetero-3-1-mer 46 x NAG, 5 x NAG-NAG HHblits 0.62
7knb.1.C
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.62 99.50 0.94 30-1227 EM 0.00 hetero-3-1-mer 46 x NAG, 5 x NAG-NAG HHblits 0.62
7kni.1.A
Spike glycoprotein
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.63 99.50 0.94 30-1227 EM 0.00 hetero-3-3-mer 56 x NAG, 6 x NAG-NAG HHblits 0.62
7kms.1.C
Spike glycoprotein
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.67 99.50 0.94 30-1227 EM 0.00 hetero-3-3-mer 55 x NAG, 8 x NAG-NAG HHblits 0.62
7mw2.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with all RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 30 x NAG, 21 x NAG-NAG HHblits 0.62
7mw5.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 2
 0.68 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 25 x NAG, 29 x NAG-NAG HHblits 0.62
7q1z.1.B
Spike glycoprotein
Structure of formaldehyde cross-linked SARS-CoV-2 S glycoprotein
 0.70 99.50 0.94 30-1227 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7mw6.1.F
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with three RBDs up in complex with the Fab fragment of human neutralizing antibody clone 2
 0.71 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 21 x NAG, 33 x NAG-NAG HHblits 0.62
7mw4.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 6
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 28 x NAG, 23 x NAG-NAG HHblits 0.62
7mw4.1.D
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 6
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 28 x NAG, 23 x NAG-NAG HHblits 0.62
7mw3.1.D
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 30 x NAG, 21 x NAG-NAG HHblits 0.62
7mw6.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with three RBDs up in complex with the Fab fragment of human neutralizing antibody clone 2
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 21 x NAG, 33 x NAG-NAG HHblits 0.62
7mw5.1.D
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 2
 0.67 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 25 x NAG, 29 x NAG-NAG HHblits 0.62
7mw4.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 6
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 28 x NAG, 23 x NAG-NAG HHblits 0.62
7mw5.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 2
 0.67 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 25 x NAG, 29 x NAG-NAG HHblits 0.62
7mw6.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with three RBDs up in complex with the Fab fragment of human neutralizing antibody clone 2
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 21 x NAG, 33 x NAG-NAG HHblits 0.62
7mw3.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 30 x NAG, 21 x NAG-NAG HHblits 0.62
7p79.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation.
 0.67 99.50 0.94 30-1227 EM 0.00 hetero-3-3-mer 19 x NAG, 4 x NAG-NAG-BMA, 8 x NAG-NAG, 3 x NAG-BMA, 1 x NAG-NAG-NAG HHblits 0.62
7p79.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation.
 0.65 99.50 0.94 30-1227 EM 0.00 hetero-3-3-mer 19 x NAG, 4 x NAG-NAG-BMA, 8 x NAG-NAG, 3 x NAG-BMA, 1 x NAG-NAG-NAG HHblits 0.62
7p79.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation.
 0.62 99.50 0.94 30-1227 EM 0.00 hetero-3-3-mer 19 x NAG, 4 x NAG-NAG-BMA, 8 x NAG-NAG, 3 x NAG-BMA, 1 x NAG-NAG-NAG HHblits 0.62
7p78.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 1up/1up-out/1down conformation
 0.62 99.50 0.94 30-1227 EM 0.00 hetero-3-3-2-mer 19 x NAG, 11 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-NAG-NAG HHblits 0.62
7p77.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 3up conformation
 0.64 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 29 x NAG, 10 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMA, 1 x NAG-NAG-NAG HHblits 0.62
7p78.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 1up/1up-out/1down conformation
 0.66 99.50 0.94 30-1227 EM 0.00 hetero-3-3-2-mer 19 x NAG, 11 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-NAG-NAG HHblits 0.62
7p77.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 3up conformation
 0.66 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 29 x NAG, 10 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMA, 1 x NAG-NAG-NAG HHblits 0.62
7x7n.1.C
Spike glycoprotein
3D model of the 3-RBD up single trimeric spike protein of SARS-CoV2 in the presence of synthetic peptide SIH-5.
 0.60 99.50 0.94 30-1227 EM 0.00 hetero-3-6-mer 39 x NAG HHblits 0.62
7x7n.1.B
Spike glycoprotein
3D model of the 3-RBD up single trimeric spike protein of SARS-CoV2 in the presence of synthetic peptide SIH-5.
 0.58 99.50 0.94 30-1227 EM 0.00 hetero-3-6-mer 39 x NAG HHblits 0.62
7x7n.1.A
Spike glycoprotein
3D model of the 3-RBD up single trimeric spike protein of SARS-CoV2 in the presence of synthetic peptide SIH-5.
 0.59 99.50 0.94 30-1227 EM 0.00 hetero-3-6-mer 39 x NAG HHblits 0.62
7nd8.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-384 Fab
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 30 x NAG, 15 x NAG-NAG HHblits 0.62
7ndc.1.C
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-159
 0.71 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 24 x NAG, 15 x NAG-NAG HHblits 0.62
7ndb.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-253H165L Fab
 0.69 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 27 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-FUC HHblits 0.62
7nd7.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 25 x NAG, 15 x NAG-NAG, 3 x NAG-NAG-FUC HHblits 0.62
7nd4.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-88 Fab
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 30 x NAG, 15 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA HHblits 0.62
7nd9.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-253H55L Fab
 0.71 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 27 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-FUC HHblits 0.62
7nd8.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-384 Fab
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 30 x NAG, 15 x NAG-NAG HHblits 0.62
7ndd.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-159
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 24 x NAG, 15 x NAG-NAG HHblits 0.62
7nd9.1.C
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-253H55L Fab
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 27 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-FUC HHblits 0.62
7nda.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-253H55L Fab
 0.69 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 32 x NAG, 14 x NAG-NAG, 1 x NAG-NAG-FUC HHblits 0.62
7nda.1.C
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-253H55L Fab
 0.69 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 32 x NAG, 14 x NAG-NAG, 1 x NAG-NAG-FUC HHblits 0.62
7ndb.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-253H165L Fab
 0.69 99.50 0.94 30-1227 EM 0.00 hetero-3-1-1-mer 27 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-FUC HHblits 0.62
6zdh.1.B
Spike glycoprotein
SARS-CoV-2 Spike glycoprotein in complex with a neutralizing antibody EY6A Fab
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 23 x NAG, 13 x NAG-NAG HHblits 0.62
7e3k.1.A
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
 0.68 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 22 x NAG HHblits 0.62
7v26.1.A
Spike glycoprotein
XG005-bound SARS-CoV-2 S
 0.65 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 45 x NAG HHblits 0.62
7v26.1.B
Spike glycoprotein
XG005-bound SARS-CoV-2 S
 0.64 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 45 x NAG HHblits 0.62
7v26.1.C
Spike glycoprotein
XG005-bound SARS-CoV-2 S
 0.65 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 45 x NAG HHblits 0.62
7e3l.1.C
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
 0.69 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 20 x NAG HHblits 0.62
7e3l.1.B
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
 0.69 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 20 x NAG HHblits 0.62
7ws0.1.C
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 30 x NAG, 18 x NAG-NAG HHblits 0.62
7ws1.1.B
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.71 99.50 0.94 30-1227 EM 0.00 hetero-3-4-4-mer 30 x NAG, 18 x NAG-NAG HHblits 0.62
7ws1.1.C
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-4-4-mer 30 x NAG, 18 x NAG-NAG HHblits 0.62
7ws0.1.B
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 30 x NAG, 18 x NAG-NAG HHblits 0.62
7ws0.1.A
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.71 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 30 x NAG, 18 x NAG-NAG HHblits 0.62
7v2a.1.A
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with XG014 Fab
 0.70 99.50 0.94 30-1227 EM 3.40 hetero-3-3-3-mer 24 x NAG HHblits 0.62
7jwb.1.D
Spike glycoprotein
SARS CoV2 Spike ectodomain with engineered trimerized VH binder
 0.68 99.50 0.94 30-1227 EM 0.00 hetero-1-3-mer HHblits 0.62
7jwb.1.B
Spike glycoprotein
SARS CoV2 Spike ectodomain with engineered trimerized VH binder
 0.68 99.50 0.94 30-1227 EM 0.00 hetero-1-3-mer HHblits 0.62
7jwb.1.C
Spike glycoprotein
SARS CoV2 Spike ectodomain with engineered trimerized VH binder
 0.69 99.50 0.94 30-1227 EM 0.00 hetero-1-3-mer HHblits 0.62
7kqe.1.C
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 3D11 complex
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer HHblits 0.62
7m71.1.A
Spike glycoprotein
SARS-CoV-2 Spike:5A6 Fab complex I focused refinement
 0.04 99.50 0.94 30-1227 EM 0.00 hetero-2-1-1-mer 4 x NAG HHblits 0.62
7kqb.1.B
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 5A6 complex I
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-2-2-mer 23 x NAG HHblits 0.62
7kqe.1.E
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 3D11 complex
 0.70 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer HHblits 0.62
7kqe.1.D
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 3D11 complex
 0.71 99.50 0.94 30-1227 EM 0.00 hetero-3-3-3-mer HHblits 0.62
7m71.1.B
Spike glycoprotein
SARS-CoV-2 Spike:5A6 Fab complex I focused refinement
 0.04 99.50 0.94 30-1227 EM 0.00 hetero-2-1-1-mer 4 x NAG HHblits 0.62
6xs6.1.A
Spike glycoprotein
SARS-CoV-2 Spike D614G variant, minus RBD
 0.50 99.67 0.93 32-1231 EM 0.00 homo-trimer BLAST 0.62
7wwl.1.A
Spike glycoprotein
S protein of Delta variant in complex with ZWD12
 0.70 97.69 0.95 30-1242 EM 0.00 hetero-3-3-3-mer 25 x NAG, 23 x NAG-NAG HHblits 0.61
7wwl.1.B
Spike glycoprotein
S protein of Delta variant in complex with ZWD12
 0.70 97.69 0.95 30-1242 EM 0.00 hetero-3-3-3-mer 25 x NAG, 23 x NAG-NAG HHblits 0.61
7wwm.1.A
Spike glycoprotein
S protein of Delta variant in complex with ZWC6
 0.70 97.69 0.95 30-1242 EM 0.00 hetero-3-3-3-mer 25 x NAG, 23 x NAG-NAG HHblits 0.61
7wwm.1.B
Spike glycoprotein
S protein of Delta variant in complex with ZWC6
 0.70 97.69 0.95 30-1242 EM 0.00 hetero-3-3-3-mer 25 x NAG, 23 x NAG-NAG HHblits 0.61
7wwm.1.C
Spike glycoprotein
S protein of Delta variant in complex with ZWC6
 0.70 97.69 0.95 30-1242 EM 0.00 hetero-3-3-3-mer 25 x NAG, 23 x NAG-NAG HHblits 0.61
7fce.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 A372T spike glycoprotein (closed)
 0.71 99.42 0.94 30-1227 EM 0.00 homo-trimer 24 x NAG, 27 x NAG-NAG HHblits 0.62
7fcd.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 A372T spike glycoprotein (open)
 0.71 99.42 0.94 30-1227 EM 0.00 homo-trimer 35 x NAG HHblits 0.62
7fcd.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 A372T spike glycoprotein (open)
 0.70 99.42 0.94 30-1227 EM 0.00 homo-trimer 35 x NAG HHblits 0.62
7fcd.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 A372T spike glycoprotein (open)
 0.70 99.42 0.94 30-1227 EM 0.00 homo-trimer 35 x NAG HHblits 0.62
6zge.1.A
Spike glycoprotein
Uncleavable Spike Protein of SARS-CoV-2 in Closed Conformation
 0.68 99.67 0.93 32-1227 EM 0.00 homo-trimer 21 x NAG, 30 x NAG-NAG HHblits 0.62
7nt9.1.B
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (closed conformation)
 0.66 99.67 0.93 32-1227 EM 0.00 homo-trimer 3 x BLA, 24 x NAG, 30 x NAG-NAG HHblits 0.62
7nta.1.B
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (one RBD erect)
 0.65 99.67 0.93 32-1227 EM 0.00 homo-trimer 3 x BLA, 27 x NAG, 25 x NAG-NAG HHblits 0.62
7nta.1.A
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (one RBD erect)
 0.65 99.67 0.93 32-1227 EM 0.00 homo-trimer 3 x BLA, 27 x NAG, 25 x NAG-NAG HHblits 0.62
7ntc.1.B
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab
 0.63 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 2 x BLA, 29 x NAG, 25 x NAG-NAG HHblits 0.62
7ntc.1.C
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab
 0.63 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 2 x BLA, 29 x NAG, 25 x NAG-NAG HHblits 0.62
7ntc.1.A
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab
 0.63 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 2 x BLA, 29 x NAG, 25 x NAG-NAG HHblits 0.62
7nta.1.C
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (one RBD erect)
 0.64 99.67 0.93 32-1227 EM 0.00 homo-trimer 3 x BLA, 27 x NAG, 25 x NAG-NAG HHblits 0.62
6zwv.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: 3 Closed RBDs
 0.69 99.42 0.94 32-1230 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG BLAST 0.61
7krq.1.A
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
 0.70 99.42 0.94 32-1230 EM 3.44 homo-trimer 24 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUC BLAST 0.61
7krr.1.A
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
 0.71 99.42 0.94 32-1230 EM 3.50 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.61
7krr.1.C
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
 0.70 99.42 0.94 32-1230 EM 3.50 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.61
7krs.1.A
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
 0.70 99.42 0.94 32-1230 EM 3.20 homo-trimer 21 x NAG, 30 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-MAN BLAST 0.61
7eh5.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-D614G variant in complex with neutralizing antibodies, RBD-chAb15 and RBD-chAb45
 0.63 99.42 0.94 30-1227 EM 0.00 hetero-3-3-3-3-3-mer 21 x NAG, 27 x NAG-NAG HHblits 0.62
7eaz.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 1
 0.63 99.42 0.94 30-1227 EM 0.00 homo-trimer 16 x NAG, 2 x NAG-NAG-BMA, 30 x NAG-NAG HHblits 0.62
7eaz.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 1
 0.62 99.42 0.94 30-1227 EM 0.00 homo-trimer 16 x NAG, 2 x NAG-NAG-BMA, 30 x NAG-NAG HHblits 0.62
7eb0.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 2
 0.63 99.42 0.94 30-1227 EM 0.00 homo-trimer 19 x NAG, 3 x NAG-NAG-BMA, 26 x NAG-NAG HHblits 0.62
7eb0.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 2
 0.62 99.42 0.94 30-1227 EM 0.00 homo-trimer 19 x NAG, 3 x NAG-NAG-BMA, 26 x NAG-NAG HHblits 0.62
7eb3.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 3
 0.64 99.42 0.94 30-1227 EM 0.00 homo-trimer 18 x NAG, 1 x NAG-NAG-BMA, 29 x NAG-NAG HHblits 0.62
7eb3.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 3
 0.63 99.42 0.94 30-1227 EM 0.00 homo-trimer 18 x NAG, 1 x NAG-NAG-BMA, 29 x NAG-NAG HHblits 0.62
7eb3.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 3
 0.62 99.42 0.94 30-1227 EM 0.00 homo-trimer 18 x NAG, 1 x NAG-NAG-BMA, 29 x NAG-NAG HHblits 0.62
7eb4.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 1
 0.62 99.42 0.94 30-1227 EM 0.00 homo-trimer 16 x NAG, 1 x NAG-NAG-BMA, 28 x NAG-NAG HHblits 0.62
7eb4.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 1
 0.62 99.42 0.94 30-1227 EM 0.00 homo-trimer 16 x NAG, 1 x NAG-NAG-BMA, 28 x NAG-NAG HHblits 0.62
7eb5.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 2
 0.62 99.42 0.94 30-1227 EM 0.00 homo-trimer 20 x NAG, 27 x NAG-NAG HHblits 0.62
7eb5.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 2
 0.62 99.42 0.94 30-1227 EM 0.00 homo-trimer 20 x NAG, 27 x NAG-NAG HHblits 0.62
7eb5.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 2
 0.60 99.42 0.94 30-1227 EM 0.00 homo-trimer 20 x NAG, 27 x NAG-NAG HHblits 0.62
7eaz.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 1
 0.63 99.42 0.94 30-1227 EM 0.00 homo-trimer 16 x NAG, 2 x NAG-NAG-BMA, 30 x NAG-NAG HHblits 0.62
7x08.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex with 2G1
 0.70 99.33 0.94 32-1230 EM 0.00 hetero-3-3-3-mer 30 x NAG, 3 x EIC, 24 x NAG-NAG BLAST 0.61
7epx.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex with GW01
 0.71 99.33 0.94 32-1230 EM 0.00 hetero-3-2-2-mer 25 x NAG, 23 x NAG-NAG BLAST 0.61
7epx.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex with GW01
 0.71 99.33 0.94 32-1230 EM 0.00 hetero-3-2-2-mer 25 x NAG, 23 x NAG-NAG BLAST 0.61
7epx.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex with GW01
 0.69 99.33 0.94 32-1230 EM 0.00 hetero-3-2-2-mer 25 x NAG, 23 x NAG-NAG BLAST 0.61
6zge.1.A
Spike glycoprotein
Uncleavable Spike Protein of SARS-CoV-2 in Closed Conformation
 0.69 99.75 0.93 32-1227 EM 0.00 homo-trimer 21 x NAG, 30 x NAG-NAG BLAST 0.62
7nt9.1.B
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (closed conformation)
 0.66 99.75 0.93 32-1227 EM 0.00 homo-trimer 3 x BLA, 24 x NAG, 30 x NAG-NAG BLAST 0.62
7nta.1.B
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (one RBD erect)
 0.66 99.75 0.93 32-1227 EM 0.00 homo-trimer 3 x BLA, 27 x NAG, 25 x NAG-NAG BLAST 0.62
7nta.1.A
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (one RBD erect)
 0.66 99.75 0.93 32-1227 EM 0.00 homo-trimer 3 x BLA, 27 x NAG, 25 x NAG-NAG BLAST 0.62
7ntc.1.B
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab
 0.64 99.75 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 2 x BLA, 29 x NAG, 25 x NAG-NAG BLAST 0.62
7ntc.1.C
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab
 0.63 99.75 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 2 x BLA, 29 x NAG, 25 x NAG-NAG BLAST 0.62
7ntc.1.A
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab
 0.63 99.75 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 2 x BLA, 29 x NAG, 25 x NAG-NAG BLAST 0.62
7nta.1.C
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (one RBD erect)
 0.65 99.75 0.93 32-1227 EM 0.00 homo-trimer 3 x BLA, 27 x NAG, 25 x NAG-NAG BLAST 0.62
7kj2.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound
 0.69 99.83 0.93 33-1227 EM 0.00 hetero-3-1-mer 36 x NAG, 17 x NAG-NAG HHblits 0.62
7kj2.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound
 0.69 99.83 0.93 33-1227 EM 0.00 hetero-3-1-mer 36 x NAG, 17 x NAG-NAG HHblits 0.62
7kj2.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound
 0.68 99.83 0.93 33-1227 EM 0.00 hetero-3-1-mer 36 x NAG, 17 x NAG-NAG HHblits 0.62
7kj3.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with two ACE2 Bound
 0.69 99.83 0.93 33-1227 EM 0.00 hetero-3-2-mer 40 x NAG, 20 x NAG-NAG HHblits 0.62
7kj4.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound
 0.69 99.83 0.93 33-1227 EM 0.00 hetero-3-3-mer 42 x NAG, 24 x NAG-NAG HHblits 0.62
7kj4.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound
 0.70 99.83 0.93 33-1227 EM 0.00 hetero-3-3-mer 42 x NAG, 24 x NAG-NAG HHblits 0.62
7kj4.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound
 0.69 99.83 0.93 33-1227 EM 0.00 hetero-3-3-mer 42 x NAG, 24 x NAG-NAG HHblits 0.62
6zgi.1.A
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Closed Conformation
 0.68 99.58 0.93 32-1227 EM 0.00 homo-trimer 24 x NAG, 27 x NAG-NAG HHblits 0.62
6zgg.1.A
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 with One RBD Erect
 0.63 99.58 0.93 32-1227 EM 0.00 homo-trimer HHblits 0.62
6zgg.1.B
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 with One RBD Erect
 0.63 99.58 0.93 32-1227 EM 0.00 homo-trimer HHblits 0.62
6zgg.1.C
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 with One RBD Erect
 0.62 99.58 0.93 32-1227 EM 0.00 homo-trimer HHblits 0.62
7a5s.1.E
Spike glycoprotein
Complex of SARS-CoV-2 spike and CR3022 Fab (Homogeneous Refinement)
 0.34 99.58 0.93 32-1227 EM 0.00 hetero-2-2-2-mer 2 x NAG-NAG HHblits 0.62
7a93.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 RBDs Erect
 0.62 99.58 0.93 32-1227 EM 0.00 homo-trimer HHblits 0.62
7a95.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction
 0.62 99.58 0.93 32-1227 EM 0.00 hetero-3-1-mer HHblits 0.62
7a96.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction
 0.62 99.58 0.93 32-1227 EM 0.00 hetero-3-1-mer HHblits 0.62
7a98.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 3 ACE2 Bound
 0.62 99.58 0.93 32-1227 EM 0.00 hetero-3-3-mer HHblits 0.62
7a94.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound
 0.66 99.58 0.93 32-1227 EM 0.00 hetero-3-1-mer 23 x NAG, 1 x ZN HHblits 0.62
7a94.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound
 0.66 99.58 0.93 32-1227 EM 0.00 hetero-3-1-mer 23 x NAG, 1 x ZN HHblits 0.62
7a94.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound
 0.67 99.58 0.93 32-1227 EM 0.00 hetero-3-1-mer 23 x NAG, 1 x ZN HHblits 0.62
7a97.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound
 0.62 99.58 0.93 32-1227 EM 0.00 hetero-3-2-mer HHblits 0.62
7a96.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction
 0.62 99.58 0.93 32-1227 EM 0.00 hetero-3-1-mer HHblits 0.62
7a97.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound
 0.62 99.58 0.93 32-1227 EM 0.00 hetero-3-2-mer HHblits 0.62
7a93.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 RBDs Erect
 0.62 99.58 0.93 32-1227 EM 0.00 homo-trimer HHblits 0.62
7a97.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound
 0.62 99.58 0.93 32-1227 EM 0.00 hetero-3-2-mer HHblits 0.62
7a96.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction
 0.62 99.58 0.93 32-1227 EM 0.00 hetero-3-1-mer HHblits 0.62
7a95.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction
 0.62 99.58 0.93 32-1227 EM 0.00 hetero-3-1-mer HHblits 0.62
7a95.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction
 0.62 99.58 0.93 32-1227 EM 0.00 hetero-3-1-mer HHblits 0.62
7a93.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 RBDs Erect
 0.62 99.58 0.93 32-1227 EM 0.00 homo-trimer HHblits 0.62
6zgh.1.B
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Intermediate Conformation
 0.63 99.58 0.93 32-1227 EM 0.00 homo-trimer HHblits 0.62
6zgh.1.A
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Intermediate Conformation
 0.54 99.58 0.93 32-1227 EM 0.00 homo-trimer HHblits 0.62
6zgh.1.C
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Intermediate Conformation
 0.63 99.58 0.93 32-1227 EM 0.00 homo-trimer HHblits 0.62
7a5r.1.C
Spike glycoprotein
Complex of SARS-CoV-2 spike and CR3022 Fab (Non-Uniform Refinement)
 0.04 99.58 0.93 32-1227 EM 0.00 hetero-2-2-2-mer 2 x NAG-NAG HHblits 0.62
7bnn.1.A
Spike glycoprotein
Open conformation of D614G SARS-CoV-2 spike with 1 Erect RBD
 0.65 99.58 0.93 32-1227 EM 0.00 homo-trimer 33 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-FUC HHblits 0.62
7bnn.1.B
Spike glycoprotein
Open conformation of D614G SARS-CoV-2 spike with 1 Erect RBD
 0.66 99.58 0.93 32-1227 EM 0.00 homo-trimer 33 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-FUC HHblits 0.62
7bnn.1.C
Spike glycoprotein
Open conformation of D614G SARS-CoV-2 spike with 1 Erect RBD
 0.66 99.58 0.93 32-1227 EM 0.00 homo-trimer 33 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-FUC HHblits 0.62
7z3z.1.A
Spike glycoprotein
Locked Wuhan SARS-CoV2 Prefusion Spike ectodomain with lipid bound
 0.69 99.17 0.94 29-1227 EM 0.00 homo-trimer 36 x NAG, 3 x STE, 15 x NAG-NAG HHblits 0.61
7e5r.1.G
Spike glycoprotein
SARS-CoV-2 S trimer with three-antibody cocktail complex
 0.65 99.67 0.93 32-1240 EM 3.60 hetero-3-3-3-3-3-3-… 15 x NAG-NAG BLAST 0.62
7e5s.1.B
Spike glycoprotein
SARS-CoV-2 S trimer with four-antibody cocktail complex
 0.62 99.67 0.93 32-1240 EM 3.60 hetero-3-2-2-2-2-3-… 12 x NAG-NAG BLAST 0.62
7e5s.1.A
Spike glycoprotein
SARS-CoV-2 S trimer with four-antibody cocktail complex
 0.63 99.67 0.93 32-1240 EM 3.60 hetero-3-2-2-2-2-3-… 12 x NAG-NAG BLAST 0.62
7e5s.1.C
Spike glycoprotein
SARS-CoV-2 S trimer with four-antibody cocktail complex
 0.63 99.67 0.93 32-1240 EM 3.60 hetero-3-2-2-2-2-3-… 12 x NAG-NAG BLAST 0.62
7byr.1.A
Spike glycoprotein
BD23-Fab in complex with the S ectodomain trimer
 0.69 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 32 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-BMA BLAST 0.62
7byr.1.B
Spike glycoprotein
BD23-Fab in complex with the S ectodomain trimer
 0.69 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 32 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-BMA BLAST 0.62
7byr.1.C
Spike glycoprotein
BD23-Fab in complex with the S ectodomain trimer
 0.69 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 32 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-BMA BLAST 0.62
7oan.1.A
Spike glycoprotein
Nanobody C5 bound to Spike
 0.72 99.67 0.93 32-1227 EM 3.00 hetero-3-3-mer 36 x NAG, 15 x NAG-NAG BLAST 0.62
7ej5.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-45
 0.65 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 24 x NAG, 24 x NAG-NAG BLAST 0.62
7ej4.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25
 0.64 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 21 x NAG, 27 x NAG-NAG BLAST 0.62
7ej4.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25
 0.64 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 21 x NAG, 27 x NAG-NAG BLAST 0.62
7ej4.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25
 0.65 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 21 x NAG, 27 x NAG-NAG BLAST 0.62
7ej5.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-45
 0.65 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 24 x NAG, 24 x NAG-NAG BLAST 0.62
7ej5.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-45
 0.65 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 24 x NAG, 24 x NAG-NAG BLAST 0.62
7ddd.1.B
Spike glycoprotein
SARS-Cov2 S protein at close state
 0.66 99.67 0.93 32-1227 EM 0.00 homo-trimer BLAST 0.62
7ddn.1.C
Spike glycoprotein
SARS-Cov2 S protein at open state
 0.66 99.67 0.93 32-1227 EM 0.00 homo-trimer BLAST 0.62
7ddn.1.A
Spike glycoprotein
SARS-Cov2 S protein at open state
 0.66 99.67 0.93 32-1227 EM 0.00 homo-trimer BLAST 0.62
7dd8.1.C
Spike glycoprotein
S-3C1-F1 structure, one RBD is up and two RBDs are down, the up RBD binds with a 3C1 fab
 0.62 99.67 0.93 32-1227 EM 0.00 hetero-1-1-3-mer BLAST 0.62
7dd8.1.D
Spike glycoprotein
S-3C1-F1 structure, one RBD is up and two RBDs are down, the up RBD binds with a 3C1 fab
 0.61 99.67 0.93 32-1227 EM 0.00 hetero-1-1-3-mer BLAST 0.62
7ddn.1.B
Spike glycoprotein
SARS-Cov2 S protein at open state
 0.66 99.67 0.93 32-1227 EM 0.00 homo-trimer BLAST 0.62
7dk3.1.C
Spike glycoprotein
SARS-CoV-2 S trimer, S-open
 0.66 99.67 0.93 32-1227 EM 0.00 homo-trimer BLAST 0.62
7dk3.1.B
Spike glycoprotein
SARS-CoV-2 S trimer, S-open
 0.67 99.67 0.93 32-1227 EM 0.00 homo-trimer BLAST 0.62
7dk3.1.A
Spike glycoprotein
SARS-CoV-2 S trimer, S-open
 0.67 99.67 0.93 32-1227 EM 0.00 homo-trimer BLAST 0.62
7df4.1.D
Spike glycoprotein
SARS-CoV-2 S-ACE2 complex
 0.67 99.67 0.93 32-1227 EM 0.00 hetero-1-3-mer 36 x NAG, 18 x NAG-NAG BLAST 0.62
7df4.1.C
Spike glycoprotein
SARS-CoV-2 S-ACE2 complex
 0.67 99.67 0.93 32-1227 EM 0.00 hetero-1-3-mer 36 x NAG, 18 x NAG-NAG BLAST 0.62
7df4.1.B
Spike glycoprotein
SARS-CoV-2 S-ACE2 complex
 0.66 99.67 0.93 32-1227 EM 0.00 hetero-1-3-mer 36 x NAG, 18 x NAG-NAG BLAST 0.62
7dd2.1.B
Spike glycoprotein
S-3C1-F2 structure, two RBDs are up and one RBD is down, the two up RBD bind with a 3C1 fab.
 0.63 99.67 0.93 32-1227 EM 0.00 hetero-3-2-2-mer BLAST 0.62
7dk5.1.E
Spike glycoprotein
S-2H2-F1 structure, one RBD is up and two RBDs are down, only up RBD binds with a 2H2 Fab
 0.63 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer BLAST 0.62
7dk5.1.B
Spike glycoprotein
S-2H2-F1 structure, one RBD is up and two RBDs are down, only up RBD binds with a 2H2 Fab
 0.63 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer BLAST 0.62
7dd2.1.A
Spike glycoprotein
S-3C1-F2 structure, two RBDs are up and one RBD is down, the two up RBD bind with a 3C1 fab.
 0.63 99.67 0.93 32-1227 EM 0.00 hetero-3-2-2-mer BLAST 0.62
7dk6.1.C
Spike glycoprotein
S-2H2-F2 structure, two RBDs are up and one RBD is down, each up RBD binds with a 2H2 Fab.
 0.68 99.67 0.93 32-1227 EM 0.00 hetero-3-2-2-mer BLAST 0.62
7dk7.1.I
Spike glycoprotein
S-2H2-F3b structure, three RBDs are up and each RBD binds with a 2H2 Fab.
 0.61 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer BLAST 0.62
7dk7.1.D
Spike glycoprotein
S-2H2-F3b structure, three RBDs are up and each RBD binds with a 2H2 Fab.
 0.65 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer BLAST 0.62
7dk4.1.D
Spike glycoprotein
S-2H2-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 2H2 Fab.
 0.68 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer BLAST 0.62
7dcc.1.D
Spike glycoprotein
S-3C1-F3b structure, all the three RBDs are in the up conformation and each of them associates with a 3C1 Fab
 0.65 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer BLAST 0.62
7dk6.1.A
Spike glycoprotein
S-2H2-F2 structure, two RBDs are up and one RBD is down, each up RBD binds with a 2H2 Fab.
 0.68 99.67 0.93 32-1227 EM 0.00 hetero-3-2-2-mer BLAST 0.62
7dcx.1.H
Spike glycoprotein
S-3C1-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 3C1 fab.
 0.64 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer BLAST 0.62
7dk5.1.A
Spike glycoprotein
S-2H2-F1 structure, one RBD is up and two RBDs are down, only up RBD binds with a 2H2 Fab
 0.63 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer BLAST 0.62
7dk4.1.C
Spike glycoprotein
S-2H2-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 2H2 Fab.
 0.69 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer BLAST 0.62
7dcc.1.H
Spike glycoprotein
S-3C1-F3b structure, all the three RBDs are in the up conformation and each of them associates with a 3C1 Fab
 0.65 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer BLAST 0.62
7dcx.1.C
Spike glycoprotein
S-3C1-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 3C1 fab.
 0.63 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer BLAST 0.62
7dd2.1.E
Spike glycoprotein
S-3C1-F2 structure, two RBDs are up and one RBD is down, the two up RBD bind with a 3C1 fab.
 0.63 99.67 0.93 32-1227 EM 0.00 hetero-3-2-2-mer BLAST 0.62
7dk6.1.B
Spike glycoprotein
S-2H2-F2 structure, two RBDs are up and one RBD is down, each up RBD binds with a 2H2 Fab.
 0.67 99.67 0.93 32-1227 EM 0.00 hetero-3-2-2-mer BLAST 0.62
7dk7.1.C
Spike glycoprotein
S-2H2-F3b structure, three RBDs are up and each RBD binds with a 2H2 Fab.
 0.65 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer BLAST 0.62
7dcc.1.G
Spike glycoprotein
S-3C1-F3b structure, all the three RBDs are in the up conformation and each of them associates with a 3C1 Fab
 0.65 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer BLAST 0.62
7dcx.1.I
Spike glycoprotein
S-3C1-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 3C1 fab.
 0.64 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer BLAST 0.62
7dk4.1.E
Spike glycoprotein
S-2H2-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 2H2 Fab.
 0.69 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer BLAST 0.62
7akd.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fragment
 0.66 99.67 0.93 32-1227 EM 0.00 hetero-3-2-2-mer 25 x NAG, 3 x FUC, 2 x MAN, 10 x NAG-NAG, 3 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x MAN-MAN BLAST 0.62
7akd.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fragment
 0.64 99.67 0.93 32-1227 EM 0.00 hetero-3-2-2-mer 25 x NAG, 3 x FUC, 2 x MAN, 10 x NAG-NAG, 3 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x MAN-MAN BLAST 0.62
7akd.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fragment
 0.65 99.67 0.93 32-1227 EM 0.00 hetero-3-2-2-mer 25 x NAG, 3 x FUC, 2 x MAN, 10 x NAG-NAG, 3 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x MAN-MAN BLAST 0.62
7nd8.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-384 Fab
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 30 x NAG, 15 x NAG-NAG BLAST 0.62
7ndc.1.C
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-159
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 24 x NAG, 15 x NAG-NAG BLAST 0.62
7ndb.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-253H165L Fab
 0.70 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 27 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-FUC BLAST 0.62
7nd7.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab
 0.70 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 25 x NAG, 15 x NAG-NAG, 3 x NAG-NAG-FUC BLAST 0.62
7nd4.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-88 Fab
 0.70 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 30 x NAG, 15 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA BLAST 0.62
7nd9.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-253H55L Fab
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 27 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-FUC BLAST 0.62
7nd8.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-384 Fab
 0.70 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 30 x NAG, 15 x NAG-NAG BLAST 0.62
7ndd.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-159
 0.70 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 24 x NAG, 15 x NAG-NAG BLAST 0.62
7nd9.1.C
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-253H55L Fab
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 27 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-FUC BLAST 0.62
7nda.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-253H55L Fab
 0.70 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 32 x NAG, 14 x NAG-NAG, 1 x NAG-NAG-FUC BLAST 0.62
7nda.1.C
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-253H55L Fab
 0.70 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 32 x NAG, 14 x NAG-NAG, 1 x NAG-NAG-FUC BLAST 0.62
7ndb.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-253H165L Fab
 0.70 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 27 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-FUC BLAST 0.62
6zdh.1.B
Spike glycoprotein
SARS-CoV-2 Spike glycoprotein in complex with a neutralizing antibody EY6A Fab
 0.70 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 23 x NAG, 13 x NAG-NAG BLAST 0.62
7kni.1.B
Spike glycoprotein
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.63 99.67 0.93 32-1227 EM 0.00 hetero-3-3-mer 56 x NAG, 6 x NAG-NAG BLAST 0.62
6zxn.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1)
 0.72 99.67 0.93 32-1227 EM 0.00 hetero-3-3-mer 39 x NAG, 12 x NAG-NAG BLAST 0.62
7a29.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up conformation
 0.70 99.67 0.93 32-1227 EM 0.00 hetero-3-3-mer 45 x NAG, 8 x NAG-NAG BLAST 0.62
7a29.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up conformation
 0.72 99.67 0.93 32-1227 EM 0.00 hetero-3-3-mer 45 x NAG, 8 x NAG-NAG BLAST 0.62
7a29.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up conformation
 0.70 99.67 0.93 32-1227 EM 0.00 hetero-3-3-mer 45 x NAG, 8 x NAG-NAG BLAST 0.62
6vsb.1.B
Spike glycoprotein
Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up
 0.70 99.67 0.93 32-1227 EM 0.00 homo-trimer 27 x NAG, 17 x NAG-NAG BLAST 0.62
6zxn.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1)
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-3-mer 39 x NAG, 12 x NAG-NAG BLAST 0.62
6xey.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4
 0.68 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 36 x NAG, 7 x NAG-NAG, 3 x NAG-NAG-BMA, 2 x NAG-BMA BLAST 0.62
6vsb.1.A
Spike glycoprotein
Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up
 0.70 99.67 0.93 32-1227 EM 0.00 homo-trimer 27 x NAG, 17 x NAG-NAG BLAST 0.62
6vsb.1.C
Spike glycoprotein
Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up
 0.70 99.67 0.93 32-1227 EM 0.00 homo-trimer 27 x NAG, 17 x NAG-NAG BLAST 0.62
6zow.1.A
Spike glycoprotein
SARS-CoV-2 spike in prefusion state
 0.53 99.67 0.93 32-1227 EM 0.00 homo-tetramer 18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMA BLAST 0.62
6zp5.1.B
Spike glycoprotein
SARS-CoV-2 spike in prefusion state (flexibility analysis, 1-up closed conformation)
 0.68 99.67 0.93 32-1227 EM 0.00 homo-trimer 18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMA BLAST 0.62
6zp5.1.A
Spike glycoprotein
SARS-CoV-2 spike in prefusion state (flexibility analysis, 1-up closed conformation)
 0.69 99.67 0.93 32-1227 EM 0.00 homo-trimer 18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMA BLAST 0.62
6zow.1.C
Spike glycoprotein
SARS-CoV-2 spike in prefusion state
 0.65 99.67 0.93 32-1227 EM 0.00 homo-tetramer 18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMA BLAST 0.62
7ks9.1.E
Spike glycoprotein
Cryo-EM structure of prefusion SARS-CoV-2 spike glycoprotein in complex with 910-30 Fab
 0.69 99.67 0.93 32-1227 EM 0.00 hetero-1-1-3-mer 35 x NAG, 12 x NAG-NAG BLAST 0.62
7ks9.1.C
Spike glycoprotein
Cryo-EM structure of prefusion SARS-CoV-2 spike glycoprotein in complex with 910-30 Fab
 0.69 99.67 0.93 32-1227 EM 0.00 hetero-1-1-3-mer 35 x NAG, 12 x NAG-NAG BLAST 0.62
7ks9.1.D
Spike glycoprotein
Cryo-EM structure of prefusion SARS-CoV-2 spike glycoprotein in complex with 910-30 Fab
 0.70 99.67 0.93 32-1227 EM 0.00 hetero-1-1-3-mer 35 x NAG, 12 x NAG-NAG BLAST 0.62
7ljr.1.B
Spike glycoprotein
SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab
 0.64 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer BLAST 0.62
7ljr.1.A
Spike glycoprotein
SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab
 0.67 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer BLAST 0.62
7ljr.1.C
Spike glycoprotein
SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab
 0.65 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer BLAST 0.62
7l57.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15
 0.61 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 31 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-NAG, 1 x NAG-NAG-BMA-NAG BLAST 0.62
7kkk.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6
 0.70 99.67 0.93 32-1227 EM 0.00 hetero-3-3-mer 30 x NAG, 12 x NAG-NAG BLAST 0.62
7l57.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15
 0.60 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 31 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-NAG, 1 x NAG-NAG-BMA-NAG BLAST 0.62
7l56.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-43
 0.69 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 31 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-NAG-GAL-MAN-MAN BLAST 0.62
7l58.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4
 0.61 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 33 x NAG, 4 x NAG-NAG BLAST 0.62
7kkl.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing nanobody mNb6
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-3-mer 27 x NAG, 18 x NAG-NAG BLAST 0.62
7l57.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15
 0.61 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 31 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-NAG, 1 x NAG-NAG-BMA-NAG BLAST 0.62
7l58.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4
 0.64 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 33 x NAG, 4 x NAG-NAG BLAST 0.62
7l58.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4
 0.65 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 33 x NAG, 4 x NAG-NAG BLAST 0.62
7b18.1.A
Spike glycoprotein
SARS-CoV-spike bound to two neutralising nanobodies
 0.70 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 42 x NAG, 1 x NAG-NAG BLAST 0.62
7b18.1.B
Spike glycoprotein
SARS-CoV-spike bound to two neutralising nanobodies
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 42 x NAG, 1 x NAG-NAG BLAST 0.62
7b18.1.C
Spike glycoprotein
SARS-CoV-spike bound to two neutralising nanobodies
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 42 x NAG, 1 x NAG-NAG BLAST 0.62
6zp7.1.C
Spike glycoprotein
SARS-CoV-2 spike in prefusion state (flexibility analysis, 1-up open conformation)
 0.65 99.67 0.93 32-1227 EM 0.00 homo-trimer 18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMA BLAST 0.62
7l2d.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.63 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 34 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-BMA BLAST 0.62
7l2d.1.D
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.65 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 34 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-BMA BLAST 0.62
7l2e.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 4-18 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.64 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 30 x NAG, 24 x NAG-NAG BLAST 0.62
7l2f.1.B
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.65 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 36 x NAG, 16 x NAG-NAG, 2 x NAG-NAG-BMA BLAST 0.62
7l2f.1.C
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.65 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 36 x NAG, 16 x NAG-NAG, 2 x NAG-NAG-BMA BLAST 0.62
7l2d.1.E
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.66 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 34 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-BMA BLAST 0.62
7l2f.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.64 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 36 x NAG, 16 x NAG-NAG, 2 x NAG-NAG-BMA BLAST 0.62
7ksg.1.C
Spike glycoprotein
SARS-CoV-2 spike in complex with nanobodies E
 0.70 99.67 0.93 32-1227 EM 0.00 hetero-3-3-mer 51 x NAG BLAST 0.62
7ksg.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with nanobodies E
 0.69 99.67 0.93 32-1227 EM 0.00 hetero-3-3-mer 51 x NAG BLAST 0.62
7ksg.1.B
Spike glycoprotein
SARS-CoV-2 spike in complex with nanobodies E
 0.69 99.67 0.93 32-1227 EM 0.00 hetero-3-3-mer 51 x NAG BLAST 0.62
7rw2.1.C
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 5-7 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.64 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 48 x NAG, 6 x NAG-NAG BLAST 0.62
7ls9.1.D
Spike glycoprotein
Cryo-EM structure of neutralizing antibody 1-57 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.66 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 30 x NAG, 3 x NAG-NAG-BMA, 18 x NAG-NAG BLAST 0.62
7lss.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7
 0.53 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 30 x NAG, 6 x NAG-NAG BLAST 0.62
7lss.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7
 0.69 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 30 x NAG, 6 x NAG-NAG BLAST 0.62
7lss.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7
 0.53 99.67 0.93 32-1227 EM 0.00 hetero-3-1-1-mer 30 x NAG, 6 x NAG-NAG BLAST 0.62
7n5h.1.B
Spike glycoprotein
Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.69 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 9 x NAG, 16 x NAG-NAG BLAST 0.62
7n5h.1.C
Spike glycoprotein
Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 9 x NAG, 16 x NAG-NAG BLAST 0.62
7n5h.1.A
Spike glycoprotein
Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.70 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 9 x NAG, 16 x NAG-NAG BLAST 0.62
7kne.1.C
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5
 0.63 99.67 0.93 32-1227 EM 0.00 hetero-3-1-mer 44 x NAG, 6 x NAG-NAG BLAST 0.62
7kms.1.B
Spike glycoprotein
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.66 99.67 0.93 32-1227 EM 0.00 hetero-3-3-mer 55 x NAG, 8 x NAG-NAG BLAST 0.62
7knh.1.B
Spike glycoprotein
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.63 99.67 0.93 32-1227 EM 0.00 hetero-3-2-mer 48 x NAG, 4 x NAG-NAG BLAST 0.62
7kne.1.B
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5
 0.64 99.67 0.93 32-1227 EM 0.00 hetero-3-1-mer 44 x NAG, 6 x NAG-NAG BLAST 0.62
7kms.1.D
Spike glycoprotein
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.67 99.67 0.93 32-1227 EM 0.00 hetero-3-3-mer 55 x NAG, 8 x NAG-NAG BLAST 0.62
7knh.1.D
Spike glycoprotein
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.64 99.67 0.93 32-1227 EM 0.00 hetero-3-2-mer 48 x NAG, 4 x NAG-NAG BLAST 0.62
6zxn.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1)
 0.72 99.67 0.93 32-1227 EM 0.00 hetero-3-3-mer 39 x NAG, 12 x NAG-NAG BLAST 0.62
7knh.1.A
Spike glycoprotein
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.66 99.67 0.93 32-1227 EM 0.00 hetero-3-2-mer 48 x NAG, 4 x NAG-NAG BLAST 0.62
7knb.1.A
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.65 99.67 0.93 32-1227 EM 0.00 hetero-3-1-mer 46 x NAG, 5 x NAG-NAG BLAST 0.62
7knb.1.C
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.62 99.67 0.93 32-1227 EM 0.00 hetero-3-1-mer 46 x NAG, 5 x NAG-NAG BLAST 0.62
7kni.1.A
Spike glycoprotein
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.63 99.67 0.93 32-1227 EM 0.00 hetero-3-3-mer 56 x NAG, 6 x NAG-NAG BLAST 0.62
7kms.1.C
Spike glycoprotein
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.67 99.67 0.93 32-1227 EM 0.00 hetero-3-3-mer 55 x NAG, 8 x NAG-NAG BLAST 0.62
7mw2.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with all RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 30 x NAG, 21 x NAG-NAG BLAST 0.62
7mw5.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 2
 0.68 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 25 x NAG, 29 x NAG-NAG BLAST 0.62
7q1z.1.B
Spike glycoprotein
Structure of formaldehyde cross-linked SARS-CoV-2 S glycoprotein
 0.71 99.67 0.93 32-1227 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG BLAST 0.62
7mw6.1.F
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with three RBDs up in complex with the Fab fragment of human neutralizing antibody clone 2
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 21 x NAG, 33 x NAG-NAG BLAST 0.62
7mw4.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 6
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 28 x NAG, 23 x NAG-NAG BLAST 0.62
7mw4.1.D
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 6
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 28 x NAG, 23 x NAG-NAG BLAST 0.62
7mw3.1.D
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 30 x NAG, 21 x NAG-NAG BLAST 0.62
7mw6.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with three RBDs up in complex with the Fab fragment of human neutralizing antibody clone 2
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 21 x NAG, 33 x NAG-NAG BLAST 0.62
7mw5.1.D
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 2
 0.67 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 25 x NAG, 29 x NAG-NAG BLAST 0.62
7mw4.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 6
 0.70 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 28 x NAG, 23 x NAG-NAG BLAST 0.62
7mw5.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 2
 0.67 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 25 x NAG, 29 x NAG-NAG BLAST 0.62
7mw6.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with three RBDs up in complex with the Fab fragment of human neutralizing antibody clone 2
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 21 x NAG, 33 x NAG-NAG BLAST 0.62
7mw3.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 30 x NAG, 21 x NAG-NAG BLAST 0.62
7p79.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation.
 0.68 99.67 0.93 32-1227 EM 0.00 hetero-3-3-mer 19 x NAG, 4 x NAG-NAG-BMA, 8 x NAG-NAG, 3 x NAG-BMA, 1 x NAG-NAG-NAG BLAST 0.62
7p79.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation.
 0.65 99.67 0.93 32-1227 EM 0.00 hetero-3-3-mer 19 x NAG, 4 x NAG-NAG-BMA, 8 x NAG-NAG, 3 x NAG-BMA, 1 x NAG-NAG-NAG BLAST 0.62
7p79.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation.
 0.62 99.67 0.93 32-1227 EM 0.00 hetero-3-3-mer 19 x NAG, 4 x NAG-NAG-BMA, 8 x NAG-NAG, 3 x NAG-BMA, 1 x NAG-NAG-NAG BLAST 0.62
7p78.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 1up/1up-out/1down conformation
 0.62 99.67 0.93 32-1227 EM 0.00 hetero-3-3-2-mer 19 x NAG, 11 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-NAG-NAG BLAST 0.62
7p77.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 3up conformation
 0.64 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 29 x NAG, 10 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMA, 1 x NAG-NAG-NAG BLAST 0.62
7p78.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 1up/1up-out/1down conformation
 0.66 99.67 0.93 32-1227 EM 0.00 hetero-3-3-2-mer 19 x NAG, 11 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-NAG-NAG BLAST 0.62
7p77.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 3up conformation
 0.66 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 29 x NAG, 10 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMA, 1 x NAG-NAG-NAG BLAST 0.62
7x7n.1.C
Spike glycoprotein
3D model of the 3-RBD up single trimeric spike protein of SARS-CoV2 in the presence of synthetic peptide SIH-5.
 0.60 99.67 0.93 32-1227 EM 0.00 hetero-3-6-mer 39 x NAG BLAST 0.62
7x7n.1.B
Spike glycoprotein
3D model of the 3-RBD up single trimeric spike protein of SARS-CoV2 in the presence of synthetic peptide SIH-5.
 0.59 99.67 0.93 32-1227 EM 0.00 hetero-3-6-mer 39 x NAG BLAST 0.62
7x7n.1.A
Spike glycoprotein
3D model of the 3-RBD up single trimeric spike protein of SARS-CoV2 in the presence of synthetic peptide SIH-5.
 0.59 99.67 0.93 32-1227 EM 0.00 hetero-3-6-mer 39 x NAG BLAST 0.62
7e3k.1.A
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
 0.68 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 22 x NAG BLAST 0.62
7v26.1.A
Spike glycoprotein
XG005-bound SARS-CoV-2 S
 0.66 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 45 x NAG BLAST 0.62
7v26.1.B
Spike glycoprotein
XG005-bound SARS-CoV-2 S
 0.64 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 45 x NAG BLAST 0.62
7v26.1.C
Spike glycoprotein
XG005-bound SARS-CoV-2 S
 0.65 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 45 x NAG BLAST 0.62
7e3l.1.C
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
 0.70 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 20 x NAG BLAST 0.62
7e3l.1.B
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
 0.70 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 20 x NAG BLAST 0.62
7ws0.1.C
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 30 x NAG, 18 x NAG-NAG BLAST 0.62
7ws1.1.B
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-4-4-mer 30 x NAG, 18 x NAG-NAG BLAST 0.62
7ws1.1.C
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-4-4-mer 30 x NAG, 18 x NAG-NAG BLAST 0.62
7ws0.1.B
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 30 x NAG, 18 x NAG-NAG BLAST 0.62
7ws0.1.A
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer 30 x NAG, 18 x NAG-NAG BLAST 0.62
7v2a.1.A
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with XG014 Fab
 0.70 99.67 0.93 32-1227 EM 3.40 hetero-3-3-3-mer 24 x NAG BLAST 0.62
7jwb.1.D
Spike glycoprotein
SARS CoV2 Spike ectodomain with engineered trimerized VH binder
 0.68 99.67 0.93 32-1227 EM 0.00 hetero-1-3-mer BLAST 0.62
7jwb.1.B
Spike glycoprotein
SARS CoV2 Spike ectodomain with engineered trimerized VH binder
 0.68 99.67 0.93 32-1227 EM 0.00 hetero-1-3-mer BLAST 0.62
7jwb.1.C
Spike glycoprotein
SARS CoV2 Spike ectodomain with engineered trimerized VH binder
 0.69 99.67 0.93 32-1227 EM 0.00 hetero-1-3-mer BLAST 0.62
7kqe.1.C
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 3D11 complex
 0.70 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer BLAST 0.62
7m71.1.A
Spike glycoprotein
SARS-CoV-2 Spike:5A6 Fab complex I focused refinement
 0.04 99.67 0.93 32-1227 EM 0.00 hetero-2-1-1-mer 4 x NAG BLAST 0.62
7kqb.1.B
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 5A6 complex I
 0.70 99.67 0.93 32-1227 EM 0.00 hetero-3-2-2-mer 23 x NAG BLAST 0.62
7kqe.1.E
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 3D11 complex
 0.70 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer BLAST 0.62
7kqe.1.D
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 3D11 complex
 0.71 99.67 0.93 32-1227 EM 0.00 hetero-3-3-3-mer BLAST 0.62
7m71.1.B
Spike glycoprotein
SARS-CoV-2 Spike:5A6 Fab complex I focused refinement
 0.04 99.67 0.93 32-1227 EM 0.00 hetero-2-1-1-mer 4 x NAG BLAST 0.62
7sc1.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, R40-1G8
 0.68 98.92 0.94 30-1232 EM 0.00 hetero-3-3-3-mer 45 x NAG HHblits 0.61
7uar.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1717
 0.65 98.92 0.94 30-1232 EM 3.50 hetero-3-3-3-mer 27 x NAG, 6 x NAG-NAG, 1 x NAG-NAG-BMA-FUC HHblits 0.61
7uar.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1717
 0.67 98.92 0.94 30-1232 EM 3.50 hetero-3-3-3-mer 27 x NAG, 6 x NAG-NAG, 1 x NAG-NAG-BMA-FUC HHblits 0.61
7uaq.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 NTD in complex with C1520, local refinement
 0.07 98.92 0.94 30-1232 EM 0.00 hetero-1-1-1-mer 4 x NAG, 3 x NAG-NAG HHblits 0.61
7uap.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1520
 0.65 98.92 0.94 30-1232 EM 0.00 hetero-3-3-3-mer 35 x NAG, 12 x NAG-NAG HHblits 0.61
7uar.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1717
 0.66 98.92 0.94 30-1232 EM 3.50 hetero-3-3-3-mer 27 x NAG, 6 x NAG-NAG, 1 x NAG-NAG-BMA-FUC HHblits 0.61
7uap.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1520
 0.63 98.92 0.94 30-1232 EM 0.00 hetero-3-3-3-mer 35 x NAG, 12 x NAG-NAG HHblits 0.61
7uap.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1520
 0.65 98.92 0.94 30-1232 EM 0.00 hetero-3-3-3-mer 35 x NAG, 12 x NAG-NAG HHblits 0.61
7r8n.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C051
 0.62 98.92 0.94 30-1232 EM 0.00 hetero-3-3-3-mer 27 x NAG, 4 x NAG-NAG HHblits 0.61
7r8m.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032
 0.64 98.92 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 22 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-FUC HHblits 0.61
7r8m.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032
 0.62 98.92 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 22 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-FUC HHblits 0.61
7r8m.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032
 0.62 98.92 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 22 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-FUC HHblits 0.61
7r8o.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C548
 0.70 98.92 0.94 30-1232 EM 0.00 hetero-3-3-3-mer 26 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-FUC, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-FUC HHblits 0.61
7rkv.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C118 (State 1)
 0.68 98.92 0.94 30-1232 EM 0.00 hetero-3-3-3-mer 39 x NAG HHblits 0.61
7s0d.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-014
 0.71 98.92 0.94 30-1232 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7s0c.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017
 0.71 98.92 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 19 x NAG, 6 x NAG-NAG HHblits 0.61
7s0d.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-014
 0.72 98.92 0.94 30-1232 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7s0d.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-014
 0.69 98.92 0.94 30-1232 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7s0e.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S1 subunit in complex with antibody N-612-004
 0.38 98.92 0.94 30-1232 EM 0.00 hetero-1-1-1-mer HHblits 0.61
7s0c.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017
 0.69 98.92 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 19 x NAG, 6 x NAG-NAG HHblits 0.61
7s0c.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017
 0.69 98.92 0.94 30-1232 EM 0.00 hetero-3-2-2-mer 19 x NAG, 6 x NAG-NAG HHblits 0.61
7tlb.1.A
Spike glycoprotein
Down-state locked rS2d SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 2
 0.70 99.33 0.94 30-1227 EM 0.00 homo-trimer HHblits 0.61
7tlb.1.B
Spike glycoprotein
Down-state locked rS2d SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 2
 0.70 99.33 0.94 30-1227 EM 0.00 homo-trimer HHblits 0.61
7tlb.1.C
Spike glycoprotein
Down-state locked rS2d SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 2
 0.70 99.33 0.94 30-1227 EM 0.00 homo-trimer HHblits 0.61
7tla.1.C
Spike glycoprotein
Down-state locked rS2d SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 1
 0.70 99.33 0.94 30-1227 EM 0.00 homo-trimer HHblits 0.61
7tla.1.B
Spike glycoprotein
Down-state locked rS2d SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 1
 0.69 99.33 0.94 30-1227 EM 0.00 homo-trimer HHblits 0.61
7n1t.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.69 97.93 0.94 30-1240 EM 3.44 homo-trimer 24 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUC HHblits 0.61
7n1q.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.72 97.93 0.94 30-1240 EM 3.44 homo-trimer 29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7n1q.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.70 97.93 0.94 30-1240 EM 3.44 homo-trimer 29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7n1q.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.70 97.93 0.94 30-1240 EM 3.44 homo-trimer 29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7e8c.1.A
Spike glycoprotein
SARS-CoV-2 S-6P in complex with 9 Fabs
 0.69 99.25 0.94 30-1227 EM 0.00 hetero-3-3-3-3-3-3-… HHblits 0.61
7e8c.1.B
Spike glycoprotein
SARS-CoV-2 S-6P in complex with 9 Fabs
 0.70 99.25 0.94 30-1227 EM 0.00 hetero-3-3-3-3-3-3-… HHblits 0.61
7e8c.1.C
Spike glycoprotein
SARS-CoV-2 S-6P in complex with 9 Fabs
 0.68 99.25 0.94 30-1227 EM 0.00 hetero-3-3-3-3-3-3-… HHblits 0.61
7cak.1.A
Spike glycoprotein
SARS-CoV-2 S trimer with three RBD in the open state and complexed with three H014 Fab
 0.66 99.25 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 30 x NAG, 15 x NAG-NAG HHblits 0.61
7cai.1.B
Spike glycoprotein
SARS-CoV-2 S trimer with two RBDs in the open state and complexed with two H014 Fab
 0.66 99.25 0.94 30-1227 EM 0.00 hetero-3-2-2-mer 30 x NAG, 15 x NAG-NAG HHblits 0.61
7cai.1.C
Spike glycoprotein
SARS-CoV-2 S trimer with two RBDs in the open state and complexed with two H014 Fab
 0.67 99.25 0.94 30-1227 EM 0.00 hetero-3-2-2-mer 30 x NAG, 15 x NAG-NAG HHblits 0.61
7cai.1.A
Spike glycoprotein
SARS-CoV-2 S trimer with two RBDs in the open state and complexed with two H014 Fab
 0.67 99.25 0.94 30-1227 EM 0.00 hetero-3-2-2-mer 30 x NAG, 15 x NAG-NAG HHblits 0.61
7cyp.1.B
SARS-CoV-2 Spike glycoprotein
Complex of SARS-CoV-2 spike trimer with its neutralizing antibody HB27
 0.67 99.25 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 29 x NAG, 15 x NAG-NAG HHblits 0.61
7cyp.1.C
SARS-CoV-2 Spike glycoprotein
Complex of SARS-CoV-2 spike trimer with its neutralizing antibody HB27
 0.66 99.25 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 29 x NAG, 15 x NAG-NAG HHblits 0.61
7fce.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 A372T spike glycoprotein (closed)
 0.71 99.58 0.93 32-1227 EM 0.00 homo-trimer 24 x NAG, 27 x NAG-NAG BLAST 0.62
7fcd.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 A372T spike glycoprotein (open)
 0.71 99.58 0.93 32-1227 EM 0.00 homo-trimer 35 x NAG BLAST 0.62
7fcd.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 A372T spike glycoprotein (open)
 0.71 99.58 0.93 32-1227 EM 0.00 homo-trimer 35 x NAG BLAST 0.62
7fcd.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 A372T spike glycoprotein (open)
 0.70 99.58 0.93 32-1227 EM 0.00 homo-trimer 35 x NAG BLAST 0.62
7kdg.1.A
Spike glycoprotein
SARS-CoV-2 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS)
 0.70 99.33 0.94 30-1227 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.61
7kdh.1.A
Spike glycoprotein
SARS-CoV-2 RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS)
 0.69 99.33 0.94 30-1227 EM 0.00 homo-trimer 49 x NAG HHblits 0.61
7kdh.1.B
Spike glycoprotein
SARS-CoV-2 RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS)
 0.66 99.33 0.94 30-1227 EM 0.00 homo-trimer 49 x NAG HHblits 0.61
7kdh.1.C
Spike glycoprotein
SARS-CoV-2 RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS)
 0.69 99.33 0.94 30-1227 EM 0.00 homo-trimer 49 x NAG HHblits 0.61
7a5r.1.C
Spike glycoprotein
Complex of SARS-CoV-2 spike and CR3022 Fab (Non-Uniform Refinement)
 0.04 99.67 0.93 32-1227 EM 0.00 hetero-2-2-2-mer 2 x NAG-NAG BLAST 0.62
6zgi.1.A
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Closed Conformation
 0.69 99.67 0.93 32-1227 EM 0.00 homo-trimer 24 x NAG, 27 x NAG-NAG BLAST 0.62
6zgg.1.A
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 with One RBD Erect
 0.64 99.67 0.93 32-1227 EM 0.00 homo-trimer BLAST 0.62
6zgg.1.B
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 with One RBD Erect
 0.64 99.67 0.93 32-1227 EM 0.00 homo-trimer BLAST 0.62
6zgg.1.C
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 with One RBD Erect
 0.63 99.67 0.93 32-1227 EM 0.00 homo-trimer BLAST 0.62
7a5s.1.E
Spike glycoprotein
Complex of SARS-CoV-2 spike and CR3022 Fab (Homogeneous Refinement)
 0.35 99.67 0.93 32-1227 EM 0.00 hetero-2-2-2-mer 2 x NAG-NAG BLAST 0.62
7a93.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 RBDs Erect
 0.62 99.67 0.93 32-1227 EM 0.00 homo-trimer BLAST 0.62
7a95.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction
 0.62 99.67 0.93 32-1227 EM 0.00 hetero-3-1-mer BLAST 0.62
7a96.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction
 0.62 99.67 0.93 32-1227 EM 0.00 hetero-3-1-mer BLAST 0.62
7a98.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 3 ACE2 Bound
 0.62 99.67 0.93 32-1227 EM 0.00 hetero-3-3-mer BLAST 0.62
7a94.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound
 0.67 99.67 0.93 32-1227 EM 0.00 hetero-3-1-mer 23 x NAG, 1 x ZN BLAST 0.62
7a94.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound
 0.67 99.67 0.93 32-1227 EM 0.00 hetero-3-1-mer 23 x NAG, 1 x ZN BLAST 0.62
7a94.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound
 0.68 99.67 0.93 32-1227 EM 0.00 hetero-3-1-mer 23 x NAG, 1 x ZN BLAST 0.62
7a97.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound
 0.63 99.67 0.93 32-1227 EM 0.00 hetero-3-2-mer BLAST 0.62
7a96.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction
 0.61 99.67 0.93 32-1227 EM 0.00 hetero-3-1-mer BLAST 0.62
7a97.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound
 0.63 99.67 0.93 32-1227 EM 0.00 hetero-3-2-mer BLAST 0.62
7a93.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 RBDs Erect
 0.62 99.67 0.93 32-1227 EM 0.00 homo-trimer BLAST 0.62
7a97.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound
 0.62 99.67 0.93 32-1227 EM 0.00 hetero-3-2-mer BLAST 0.62
7a96.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction
 0.62 99.67 0.93 32-1227 EM 0.00 hetero-3-1-mer BLAST 0.62
7a95.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction
 0.62 99.67 0.93 32-1227 EM 0.00 hetero-3-1-mer BLAST 0.62
7a95.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction
 0.62 99.67 0.93 32-1227 EM 0.00 hetero-3-1-mer BLAST 0.62
7a93.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 RBDs Erect
 0.62 99.67 0.93 32-1227 EM 0.00 homo-trimer BLAST 0.62
6zgh.1.B
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Intermediate Conformation
 0.64 99.67 0.93 32-1227 EM 0.00 homo-trimer BLAST 0.62
6zgh.1.A
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Intermediate Conformation
 0.54 99.67 0.93 32-1227 EM 0.00 homo-trimer BLAST 0.62
6zgh.1.C
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Intermediate Conformation
 0.64 99.67 0.93 32-1227 EM 0.00 homo-trimer BLAST 0.62
7bnn.1.A
Spike glycoprotein
Open conformation of D614G SARS-CoV-2 spike with 1 Erect RBD
 0.66 99.67 0.93 32-1227 EM 0.00 homo-trimer 33 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-FUC BLAST 0.62
7bnn.1.B
Spike glycoprotein
Open conformation of D614G SARS-CoV-2 spike with 1 Erect RBD
 0.67 99.67 0.93 32-1227 EM 0.00 homo-trimer 33 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-FUC BLAST 0.62
7bnn.1.C
Spike glycoprotein
Open conformation of D614G SARS-CoV-2 spike with 1 Erect RBD
 0.67 99.67 0.93 32-1227 EM 0.00 homo-trimer 33 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-FUC BLAST 0.62
7eh5.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-D614G variant in complex with neutralizing antibodies, RBD-chAb15 and RBD-chAb45
 0.64 99.58 0.93 32-1227 EM 0.00 hetero-3-3-3-3-3-mer 21 x NAG, 27 x NAG-NAG BLAST 0.62
7eaz.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 1
 0.63 99.58 0.93 32-1227 EM 0.00 homo-trimer 16 x NAG, 2 x NAG-NAG-BMA, 30 x NAG-NAG BLAST 0.62
7eaz.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 1
 0.62 99.58 0.93 32-1227 EM 0.00 homo-trimer 16 x NAG, 2 x NAG-NAG-BMA, 30 x NAG-NAG BLAST 0.62
7eb0.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 2
 0.63 99.58 0.93 32-1227 EM 0.00 homo-trimer 19 x NAG, 3 x NAG-NAG-BMA, 26 x NAG-NAG BLAST 0.62
7eb0.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 2
 0.63 99.58 0.93 32-1227 EM 0.00 homo-trimer 19 x NAG, 3 x NAG-NAG-BMA, 26 x NAG-NAG BLAST 0.62
7eb3.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 3
 0.64 99.58 0.93 32-1227 EM 0.00 homo-trimer 18 x NAG, 1 x NAG-NAG-BMA, 29 x NAG-NAG BLAST 0.62
7eb3.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 3
 0.63 99.58 0.93 32-1227 EM 0.00 homo-trimer 18 x NAG, 1 x NAG-NAG-BMA, 29 x NAG-NAG BLAST 0.62
7eb3.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 3
 0.62 99.58 0.93 32-1227 EM 0.00 homo-trimer 18 x NAG, 1 x NAG-NAG-BMA, 29 x NAG-NAG BLAST 0.62
7eb4.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 1
 0.62 99.58 0.93 32-1227 EM 0.00 homo-trimer 16 x NAG, 1 x NAG-NAG-BMA, 28 x NAG-NAG BLAST 0.62
7eb4.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 1
 0.62 99.58 0.93 32-1227 EM 0.00 homo-trimer 16 x NAG, 1 x NAG-NAG-BMA, 28 x NAG-NAG BLAST 0.62
7eb5.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 2
 0.62 99.58 0.93 32-1227 EM 0.00 homo-trimer 20 x NAG, 27 x NAG-NAG BLAST 0.62
7eb5.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 2
 0.63 99.58 0.93 32-1227 EM 0.00 homo-trimer 20 x NAG, 27 x NAG-NAG BLAST 0.62
7eb5.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 2
 0.60 99.58 0.93 32-1227 EM 0.00 homo-trimer 20 x NAG, 27 x NAG-NAG BLAST 0.62
7eaz.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 1
 0.64 99.58 0.93 32-1227 EM 0.00 homo-trimer 16 x NAG, 2 x NAG-NAG-BMA, 30 x NAG-NAG BLAST 0.62
7lqv.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 4-8 Fab in complex with SARS-CoV-2 S2P spike
 0.64 99.75 0.93 33-1227 EM 0.00 hetero-3-3-3-mer 27 x NAG HHblits 0.62
7lqv.1.B
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 4-8 Fab in complex with SARS-CoV-2 S2P spike
 0.62 99.75 0.93 33-1227 EM 0.00 hetero-3-3-3-mer 27 x NAG HHblits 0.62
7lqv.1.C
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 4-8 Fab in complex with SARS-CoV-2 S2P spike
 0.65 99.75 0.93 33-1227 EM 0.00 hetero-3-3-3-mer 27 x NAG HHblits 0.62
7lqw.1.E
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike
 0.63 99.75 0.93 33-1227 EM 0.00 hetero-1-1-3-mer 25 x NAG HHblits 0.62
7lqw.1.C
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike
 0.61 99.75 0.93 33-1227 EM 0.00 hetero-1-1-3-mer 25 x NAG HHblits 0.62
7lqw.1.D
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike
 0.61 99.75 0.93 33-1227 EM 0.00 hetero-1-1-3-mer 25 x NAG HHblits 0.62
7vnc.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UDD-state, state 1)
 0.62 99.75 0.93 33-1227 EM 0.00 hetero-3-1-mer 18 x NAG, 3 x NAG-NAG-NAG, 12 x NAG-NAG HHblits 0.62
7vnc.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UDD-state, state 1)
 0.64 99.75 0.93 33-1227 EM 0.00 hetero-3-1-mer 18 x NAG, 3 x NAG-NAG-NAG, 12 x NAG-NAG HHblits 0.62
7vnc.1.D
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UDD-state, state 1)
 0.64 99.75 0.93 33-1227 EM 0.00 hetero-3-1-mer 18 x NAG, 3 x NAG-NAG-NAG, 12 x NAG-NAG HHblits 0.62
7vnd.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UUD-state, state 2)
 0.65 99.75 0.93 33-1227 EM 0.00 hetero-3-2-mer 20 x NAG, 16 x NAG-NAG HHblits 0.62
7vnd.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UUD-state, state 2)
 0.61 99.75 0.93 33-1227 EM 0.00 hetero-3-2-mer 20 x NAG, 16 x NAG-NAG HHblits 0.62
7vnd.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UUD-state, state 2)
 0.63 99.75 0.93 33-1227 EM 0.00 hetero-3-2-mer 20 x NAG, 16 x NAG-NAG HHblits 0.62
7vne.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113.1 (UUU-state)
 0.63 99.75 0.93 33-1227 EM 0.00 hetero-3-3-mer 21 x NAG, 20 x NAG-NAG, 2 x NAG-NAG-NAG HHblits 0.62
7vne.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113.1 (UUU-state)
 0.64 99.75 0.93 33-1227 EM 0.00 hetero-3-3-mer 21 x NAG, 20 x NAG-NAG, 2 x NAG-NAG-NAG HHblits 0.62
7vne.1.E
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113.1 (UUU-state)
 0.62 99.75 0.93 33-1227 EM 0.00 hetero-3-3-mer 21 x NAG, 20 x NAG-NAG, 2 x NAG-NAG-NAG HHblits 0.62
6xlu.1.A
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 4.0
 0.70 99.75 0.93 33-1227 EM 0.00 homo-trimer 32 x NAG, 15 x NAG-NAG HHblits 0.62
6xm0.1.A
Spike glycoprotein
Consensus structure of SARS-CoV-2 spike at pH 5.5
 0.69 99.75 0.93 33-1227 EM 0.00 homo-trimer 28 x NAG, 14 x NAG-NAG HHblits 0.62
6xm0.1.B
Spike glycoprotein
Consensus structure of SARS-CoV-2 spike at pH 5.5
 0.62 99.75 0.93 33-1227 EM 0.00 homo-trimer 28 x NAG, 14 x NAG-NAG HHblits 0.62
6xm0.1.C
Spike glycoprotein
Consensus structure of SARS-CoV-2 spike at pH 5.5
 0.69 99.75 0.93 33-1227 EM 0.00 homo-trimer 28 x NAG, 14 x NAG-NAG HHblits 0.62
6xm3.1.B
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 5.5, single RBD up, conformation 1
 0.66 99.75 0.93 33-1227 EM 0.00 homo-trimer 26 x NAG, 17 x NAG-NAG HHblits 0.62
6xm3.1.C
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 5.5, single RBD up, conformation 1
 0.69 99.75 0.93 33-1227 EM 0.00 homo-trimer 26 x NAG, 17 x NAG-NAG HHblits 0.62
6xm4.1.A
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 5.5, single RBD up, conformation 2
 0.68 99.75 0.93 33-1227 EM 0.00 homo-trimer 25 x NAG, 18 x NAG-NAG HHblits 0.62
6xm4.1.B
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 5.5, single RBD up, conformation 2
 0.65 99.75 0.93 33-1227 EM 0.00 homo-trimer 25 x NAG, 18 x NAG-NAG HHblits 0.62
6xm4.1.C
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 5.5, single RBD up, conformation 2
 0.69 99.75 0.93 33-1227 EM 0.00 homo-trimer 25 x NAG, 18 x NAG-NAG HHblits 0.62
6xm5.1.A
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 5.5, all RBDs down
 0.67 99.75 0.93 33-1227 EM 0.00 homo-trimer 26 x NAG, 16 x NAG-NAG HHblits 0.62
6xm5.1.B
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 5.5, all RBDs down
 0.66 99.75 0.93 33-1227 EM 0.00 homo-trimer 26 x NAG, 16 x NAG-NAG HHblits 0.62
6xm5.1.C
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 5.5, all RBDs down
 0.66 99.75 0.93 33-1227 EM 0.00 homo-trimer 26 x NAG, 16 x NAG-NAG HHblits 0.62
7jwy.1.C
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 4.5
 0.70 99.75 0.93 33-1227 EM 0.00 homo-trimer 30 x NAG, 17 x NAG-NAG HHblits 0.62
6xf5.1.A
Spike glycoprotein
Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (RBDs down)
 0.70 99.75 0.93 33-1227 EM 0.00 homo-trimer 36 x NAG, 12 x NAG-NAG HHblits 0.62
6xf6.1.A
Spike glycoprotein
Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (1 RBD up)
 0.69 99.75 0.93 33-1227 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.62
6xf6.1.B
Spike glycoprotein
Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (1 RBD up)
 0.68 99.75 0.93 33-1227 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.62
6xf6.1.C
Spike glycoprotein
Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (1 RBD up)
 0.68 99.75 0.93 33-1227 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.62
7tb8.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1
 0.65 99.75 0.93 33-1227 EM 0.00 hetero-3-3-3-1-1-mer 25 x NAG, 9 x NAG-NAG HHblits 0.62
7tb8.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1
 0.65 99.75 0.93 33-1227 EM 0.00 hetero-3-3-3-1-1-mer 25 x NAG, 9 x NAG-NAG HHblits 0.62
7tb8.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1
 0.62 99.75 0.93 33-1227 EM 0.00 hetero-3-3-3-1-1-mer 25 x NAG, 9 x NAG-NAG HHblits 0.62
6xf5.1.A
Spike glycoprotein
Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (RBDs down)
 0.70 99.75 0.93 33-1227 EM 0.00 homo-trimer 36 x NAG, 12 x NAG-NAG BLAST 0.62
6xf6.1.A
Spike glycoprotein
Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (1 RBD up)
 0.69 99.75 0.93 33-1227 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG BLAST 0.62
6xf6.1.B
Spike glycoprotein
Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (1 RBD up)
 0.69 99.75 0.93 33-1227 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG BLAST 0.62
6xf6.1.C
Spike glycoprotein
Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (1 RBD up)
 0.69 99.75 0.93 33-1227 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG BLAST 0.62
7sc1.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, R40-1G8
 0.68 99.42 0.93 32-1231 EM 0.00 hetero-3-3-3-mer 45 x NAG BLAST 0.62
7uar.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1717
 0.64 99.42 0.93 32-1231 EM 3.50 hetero-3-3-3-mer 27 x NAG, 6 x NAG-NAG, 1 x NAG-NAG-BMA-FUC BLAST 0.62
7uar.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1717
 0.67 99.42 0.93 32-1231 EM 3.50 hetero-3-3-3-mer 27 x NAG, 6 x NAG-NAG, 1 x NAG-NAG-BMA-FUC BLAST 0.62
7uaq.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 NTD in complex with C1520, local refinement
 0.08 99.42 0.93 32-1231 EM 0.00 hetero-1-1-1-mer 4 x NAG, 3 x NAG-NAG BLAST 0.62
7uap.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1520
 0.65 99.42 0.93 32-1231 EM 0.00 hetero-3-3-3-mer 35 x NAG, 12 x NAG-NAG BLAST 0.62
7uar.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1717
 0.65 99.42 0.93 32-1231 EM 3.50 hetero-3-3-3-mer 27 x NAG, 6 x NAG-NAG, 1 x NAG-NAG-BMA-FUC BLAST 0.62
7uap.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1520
 0.63 99.42 0.93 32-1231 EM 0.00 hetero-3-3-3-mer 35 x NAG, 12 x NAG-NAG BLAST 0.62
7uap.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1520
 0.65 99.42 0.93 32-1231 EM 0.00 hetero-3-3-3-mer 35 x NAG, 12 x NAG-NAG BLAST 0.62
7r8n.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C051
 0.63 99.42 0.93 32-1231 EM 0.00 hetero-3-3-3-mer 27 x NAG, 4 x NAG-NAG BLAST 0.62
7r8m.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032
 0.64 99.42 0.93 32-1231 EM 0.00 hetero-3-2-2-mer 22 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-FUC BLAST 0.62
7r8m.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032
 0.62 99.42 0.93 32-1231 EM 0.00 hetero-3-2-2-mer 22 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-FUC BLAST 0.62
7r8m.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032
 0.62 99.42 0.93 32-1231 EM 0.00 hetero-3-2-2-mer 22 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-FUC BLAST 0.62
7r8o.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C548
 0.70 99.42 0.93 32-1231 EM 0.00 hetero-3-3-3-mer 26 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-FUC, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-FUC BLAST 0.62
7rkv.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C118 (State 1)
 0.69 99.42 0.93 32-1231 EM 0.00 hetero-3-3-3-mer 39 x NAG BLAST 0.62
7s0d.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-014
 0.71 99.42 0.93 32-1231 EM 0.00 hetero-3-3-3-mer BLAST 0.62
7s0c.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017
 0.71 99.42 0.93 32-1231 EM 0.00 hetero-3-2-2-mer 19 x NAG, 6 x NAG-NAG BLAST 0.62
7s0d.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-014
 0.71 99.42 0.93 32-1231 EM 0.00 hetero-3-3-3-mer BLAST 0.62
7s0d.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-014
 0.68 99.42 0.93 32-1231 EM 0.00 hetero-3-3-3-mer BLAST 0.62
7s0e.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S1 subunit in complex with antibody N-612-004
 0.38 99.42 0.93 32-1231 EM 0.00 hetero-1-1-1-mer BLAST 0.62
7s0c.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017
 0.69 99.42 0.93 32-1231 EM 0.00 hetero-3-2-2-mer 19 x NAG, 6 x NAG-NAG BLAST 0.62
7s0c.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017
 0.69 99.42 0.93 32-1231 EM 0.00 hetero-3-2-2-mer 19 x NAG, 6 x NAG-NAG BLAST 0.62
7mxp.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody LP5 Fab in complex with SARS-CoV-2 S2P spike
 0.62 99.25 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 28 x NAG, 3 x NAG-NAG-BMA-MAN-NAG-NAG-BMA-FUC, 3 x NAG-NAG, 1 x NAG-NAG-BMA HHblits 0.61
7mxp.1.B
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody LP5 Fab in complex with SARS-CoV-2 S2P spike
 0.61 99.25 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 28 x NAG, 3 x NAG-NAG-BMA-MAN-NAG-NAG-BMA-FUC, 3 x NAG-NAG, 1 x NAG-NAG-BMA HHblits 0.61
7mxp.1.C
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody LP5 Fab in complex with SARS-CoV-2 S2P spike
 0.63 99.25 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 28 x NAG, 3 x NAG-NAG-BMA-MAN-NAG-NAG-BMA-FUC, 3 x NAG-NAG, 1 x NAG-NAG-BMA HHblits 0.61
7wuh.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with Fab of m31A7
 0.57 99.75 0.93 33-1227 EM 0.00 hetero-3-3-3-mer 19 x NAG, 2 x NAG-NAG-FUC, 8 x NAG-NAG, 2 x NAG-NAG-BMA-MAN, 4 x NAG-NAG-BMA, 3 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA-FUC, 1 x NAG-FUC, 1 x NAG-NAG-BMA-MAN-NAG-MAN, 1 x NAG-NAG-BMA-MAN-MAN-MAN HHblits 0.62
7wuh.1.B
Spike glycoprotein
SARS-CoV-2 Spike in complex with Fab of m31A7
 0.56 99.75 0.93 33-1227 EM 0.00 hetero-3-3-3-mer 19 x NAG, 2 x NAG-NAG-FUC, 8 x NAG-NAG, 2 x NAG-NAG-BMA-MAN, 4 x NAG-NAG-BMA, 3 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA-FUC, 1 x NAG-FUC, 1 x NAG-NAG-BMA-MAN-NAG-MAN, 1 x NAG-NAG-BMA-MAN-MAN-MAN HHblits 0.62
7wuh.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with Fab of m31A7
 0.56 99.75 0.93 33-1227 EM 0.00 hetero-3-3-3-mer 19 x NAG, 2 x NAG-NAG-FUC, 8 x NAG-NAG, 2 x NAG-NAG-BMA-MAN, 4 x NAG-NAG-BMA, 3 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA-FUC, 1 x NAG-FUC, 1 x NAG-NAG-BMA-MAN-NAG-MAN, 1 x NAG-NAG-BMA-MAN-MAN-MAN HHblits 0.62
6zp1.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein Trimer (K986P, V987P, single Arg S1/S2 cleavage site) in Closed State
 0.71 99.92 0.93 33-1230 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG BLAST 0.62
7kdk.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G)
 0.69 99.25 0.94 30-1227 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.61
7kdl.1.A
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G)
 0.69 99.25 0.94 30-1227 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.61
7kdl.1.B
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G)
 0.67 99.25 0.94 30-1227 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.61
7kdl.1.C
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G)
 0.69 99.25 0.94 30-1227 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.61
7ke4.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-class)
 0.69 99.25 0.94 30-1227 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.61
7ke4.1.B
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-class)
 0.69 99.25 0.94 30-1227 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.61
7ke4.1.C
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-class)
 0.69 99.25 0.94 30-1227 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.61
7ke6.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
 0.70 99.25 0.94 30-1227 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.61
7ke6.1.B
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
 0.69 99.25 0.94 30-1227 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.61
7ke6.1.C
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
 0.69 99.25 0.94 30-1227 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.61
7ke7.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3-RBD-down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
 0.68 99.25 0.94 30-1227 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.61
7ke7.1.B
Spike glycoprotein
SARS-CoV-2 D614G 3-RBD-down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
 0.69 99.25 0.94 30-1227 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.61
7ke7.1.C
Spike glycoprotein
SARS-CoV-2 D614G 3-RBD-down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
 0.69 99.25 0.94 30-1227 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.61
7kea.1.A
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub classification)
 0.68 99.25 0.94 30-1227 EM 0.00 homo-trimer 34 x NAG, 12 x NAG-NAG HHblits 0.61
7kea.1.B
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub classification)
 0.67 99.25 0.94 30-1227 EM 0.00 homo-trimer 34 x NAG, 12 x NAG-NAG HHblits 0.61
7kea.1.C
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub classification)
 0.68 99.25 0.94 30-1227 EM 0.00 homo-trimer 34 x NAG, 12 x NAG-NAG HHblits 0.61
7keb.1.A
Spike glycoprotein
SARS-CoV-2 D614G 1RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
 0.67 99.25 0.94 30-1227 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.61
7keb.1.B
Spike glycoprotein
SARS-CoV-2 D614G 1RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
 0.64 99.25 0.94 30-1227 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.61
7keb.1.C
Spike glycoprotein
SARS-CoV-2 D614G 1RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
 0.66 99.25 0.94 30-1227 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.61
7kec.1.A
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
 0.64 99.25 0.94 30-1227 EM 0.00 homo-trimer 33 x NAG, 12 x NAG-NAG HHblits 0.61
7kec.1.B
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
 0.63 99.25 0.94 30-1227 EM 0.00 homo-trimer 33 x NAG, 12 x NAG-NAG HHblits 0.61
7kec.1.C
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
 0.66 99.25 0.94 30-1227 EM 0.00 homo-trimer 33 x NAG, 12 x NAG-NAG HHblits 0.61
7ke8.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
 0.70 99.25 0.94 30-1227 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.61
7ke8.1.C
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
 0.69 99.25 0.94 30-1227 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.61
7ke8.1.B
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
 0.70 99.25 0.94 30-1227 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.61
7kl9.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the ACE2 protein decoy, CTC-445.2 (State 4)
 0.67 99.17 0.94 30-1227 EM 0.00 hetero-3-3-mer 27 x NAG, 2 x NAG-NAG HHblits 0.61
7kl9.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the ACE2 protein decoy, CTC-445.2 (State 4)
 0.65 99.17 0.94 30-1227 EM 0.00 hetero-3-3-mer 27 x NAG, 2 x NAG-NAG HHblits 0.61
7kl9.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the ACE2 protein decoy, CTC-445.2 (State 4)
 0.66 99.17 0.94 30-1227 EM 0.00 hetero-3-3-mer 27 x NAG, 2 x NAG-NAG HHblits 0.61
7fae.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P36-5D2(state2)
 0.70 99.17 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 27 x NAG, 17 x NAG-NAG HHblits 0.61
7fae.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P36-5D2(state2)
 0.70 99.17 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 27 x NAG, 17 x NAG-NAG HHblits 0.61
7fae.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P36-5D2(state2)
 0.70 99.17 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 27 x NAG, 17 x NAG-NAG HHblits 0.61
7faf.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P36-5D2 (state1)
 0.69 99.17 0.94 30-1227 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7faf.1.H
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P36-5D2 (state1)
 0.68 99.17 0.94 30-1227 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7faf.1.I
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P36-5D2 (state1)
 0.67 99.17 0.94 30-1227 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7sn2.1.A
Spike glycoprotein
Structure of human SARS-CoV-2 neutralizing antibody C1C-A3 Fab
 0.02 99.17 0.94 30-1227 EM 0.00 hetero-1-1-1-mer HHblits 0.61
7sn3.1.A
Spike glycoprotein
Structure of human SARS-CoV-2 spike glycoprotein trimer bound by neutralizing antibody C1C-A3 Fab (variable region)
 0.65 99.17 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 45 x NAG, 3 x NAG-NAG-BMA HHblits 0.61
7sn3.1.B
Spike glycoprotein
Structure of human SARS-CoV-2 spike glycoprotein trimer bound by neutralizing antibody C1C-A3 Fab (variable region)
 0.65 99.17 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 45 x NAG, 3 x NAG-NAG-BMA HHblits 0.61
7sn3.1.C
Spike glycoprotein
Structure of human SARS-CoV-2 spike glycoprotein trimer bound by neutralizing antibody C1C-A3 Fab (variable region)
 0.64 99.17 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 45 x NAG, 3 x NAG-NAG-BMA HHblits 0.61
7rq6.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with non-neutralizing NTD-directed CV3-13 Fab isolated from convalescent individual
 0.62 99.17 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 36 x NAG, 3 x NAG-NAG HHblits 0.61
7jzl.1.E
Spike glycoprotein
SARS-CoV-2 spike in complex with LCB1 (2RBDs open)
 0.70 99.17 0.94 30-1227 EM 0.00 hetero-3-3-mer 33 x NAG, 13 x NAG-NAG HHblits 0.61
6xkl.1.B
Spike glycoprotein
SARS-CoV-2 HexaPro S One RBD up
 0.70 99.17 0.94 30-1227 EM 0.00 homo-trimer 28 x NAG, 11 x NAG-NAG HHblits 0.61
6xkl.1.A
Spike glycoprotein
SARS-CoV-2 HexaPro S One RBD up
 0.69 99.17 0.94 30-1227 EM 0.00 homo-trimer 28 x NAG, 11 x NAG-NAG HHblits 0.61
6xkl.1.C
Spike glycoprotein
SARS-CoV-2 HexaPro S One RBD up
 0.70 99.17 0.94 30-1227 EM 0.00 homo-trimer 28 x NAG, 11 x NAG-NAG HHblits 0.61
7jzn.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with LCB3 (2RBDs open)
 0.71 99.17 0.94 30-1227 EM 0.00 hetero-3-3-mer 33 x NAG, 13 x NAG-NAG HHblits 0.61
7jzl.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with LCB1 (2RBDs open)
 0.71 99.17 0.94 30-1227 EM 0.00 hetero-3-3-mer 33 x NAG, 13 x NAG-NAG HHblits 0.61
7k4n.1.G
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment
 0.70 99.17 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 33 x NAG, 15 x NAG-NAG HHblits 0.61
7k90.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C144
 0.69 99.17 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 33 x NAG HHblits 0.61
7lxy.1.A
Spike glycoprotein
SARS-CoV-2 S/S2M11/S2X333 Global Refinement
 0.71 99.17 0.94 30-1227 EM 0.00 hetero-3-3-3-3-3-mer 45 x NAG, 3 x NAG-NAG-BMA-FUC, 6 x NAG-NAG HHblits 0.61
7lxz.1.F
Spike glycoprotein
SARS-CoV-2 S/S2M11/S2L28 Global Refinement
 0.71 99.17 0.94 30-1227 EM 0.00 hetero-3-3-3-3-3-mer 39 x NAG, 3 x NAG-NAG-BMA-FUC, 9 x NAG-NAG, 3 x NAG-NAG-FUC HHblits 0.61
7ly0.1.A
Spike glycoprotein
SARS-CoV-2 S/S2M11/S2M28 Local Refinement
 0.00 99.17 0.94 30-1227 EM 0.00 hetero-1-1-1-mer 2 x NAG, 1 x NAG-NAG-MAN-FUC HHblits 0.61
7m6f.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG1-22
 0.69 99.17 0.94 30-1227 EM 0.00 hetero-3-2-2-mer 33 x NAG, 15 x NAG-NAG HHblits 0.61
7m6g.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG7-15
 0.67 99.17 0.94 30-1227 EM 0.00 hetero-3-2-2-mer 26 x NAG, 11 x NAG-NAG HHblits 0.61
7m6g.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG7-15
 0.66 99.17 0.94 30-1227 EM 0.00 hetero-3-2-2-mer 26 x NAG, 11 x NAG-NAG HHblits 0.61
7m6e.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG10-19
 0.69 99.17 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 32 x NAG, 1 x NAG-NAG-FUC HHblits 0.61
7m6f.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG1-22
 0.68 99.17 0.94 30-1227 EM 0.00 hetero-3-2-2-mer 33 x NAG, 15 x NAG-NAG HHblits 0.61
7m6f.1.E
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG1-22
 0.69 99.17 0.94 30-1227 EM 0.00 hetero-3-2-2-mer 33 x NAG, 15 x NAG-NAG HHblits 0.61
7m6g.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG7-15
 0.66 99.17 0.94 30-1227 EM 0.00 hetero-3-2-2-mer 26 x NAG, 11 x NAG-NAG HHblits 0.61
7my2.1.C
Spike glycoprotein
CryoEM structure of neutralizing nanobody Nb30 in complex with SARS-CoV2 spike
 0.66 99.17 0.94 30-1227 EM 0.00 hetero-3-3-mer 29 x NAG, 11 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMA HHblits 0.61
7my2.1.A
Spike glycoprotein
CryoEM structure of neutralizing nanobody Nb30 in complex with SARS-CoV2 spike
 0.67 99.17 0.94 30-1227 EM 0.00 hetero-3-3-mer 29 x NAG, 11 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMA HHblits 0.61
7my3.1.B
Spike glycoprotein
CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike
 0.66 99.17 0.94 30-1227 EM 0.00 hetero-3-3-mer 22 x NAG, 5 x NAG-NAG-BMA, 13 x NAG-NAG HHblits 0.61
7my3.1.A
Spike glycoprotein
CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike
 0.70 99.17 0.94 30-1227 EM 0.00 hetero-3-3-mer 22 x NAG, 5 x NAG-NAG-BMA, 13 x NAG-NAG HHblits 0.61
7my3.1.C
Spike glycoprotein
CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike
 0.67 99.17 0.94 30-1227 EM 0.00 hetero-3-3-mer 22 x NAG, 5 x NAG-NAG-BMA, 13 x NAG-NAG HHblits 0.61
7my2.1.B
Spike glycoprotein
CryoEM structure of neutralizing nanobody Nb30 in complex with SARS-CoV2 spike
 0.66 99.17 0.94 30-1227 EM 0.00 hetero-3-3-mer 29 x NAG, 11 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMA HHblits 0.61
7ra8.1.A
Spike glycoprotein
SARS-CoV-2 S glycoprotein in complex with S2X259 Fab
 0.67 99.17 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 30 x NAG, 12 x NAG-NAG HHblits 0.61
7n0g.1.B
Spike glycoprotein
CryoEm structure of SARS-CoV-2 spike protein (S-6P, 1-up) in complex with sybodies (Sb45)
 0.69 99.17 0.94 30-1227 EM 0.00 hetero-3-3-mer 35 x NAG, 19 x NAG-NAG HHblits 0.61
7n0h.1.C
Spike glycoprotein
CryoEM structure of SARS-CoV-2 spike protein (S-6P, 2-up) in complex with sybodies (Sb45)
 0.68 99.17 0.94 30-1227 EM 0.00 hetero-3-2-mer 30 x NAG, 17 x NAG-NAG HHblits 0.61
7n0h.1.B
Spike glycoprotein
CryoEM structure of SARS-CoV-2 spike protein (S-6P, 2-up) in complex with sybodies (Sb45)
 0.67 99.17 0.94 30-1227 EM 0.00 hetero-3-2-mer 30 x NAG, 17 x NAG-NAG HHblits 0.61
7n0g.1.A
Spike glycoprotein
CryoEm structure of SARS-CoV-2 spike protein (S-6P, 1-up) in complex with sybodies (Sb45)
 0.68 99.17 0.94 30-1227 EM 0.00 hetero-3-3-mer 35 x NAG, 19 x NAG-NAG HHblits 0.61
7n0g.1.C
Spike glycoprotein
CryoEm structure of SARS-CoV-2 spike protein (S-6P, 1-up) in complex with sybodies (Sb45)
 0.68 99.17 0.94 30-1227 EM 0.00 hetero-3-3-mer 35 x NAG, 19 x NAG-NAG HHblits 0.61
7e9o.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(3 up RBDs, state2)
 0.66 99.17 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 27 x NAG HHblits 0.61
7e9q.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 out RBD, state3)
 0.66 99.17 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 27 x NAG HHblits 0.61
7e9q.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 out RBD, state3)
 0.63 99.17 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 27 x NAG HHblits 0.61
7e9o.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(3 up RBDs, state2)
 0.67 99.17 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 27 x NAG HHblits 0.61
7e9q.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 out RBD, state3)
 0.65 99.17 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 27 x NAG HHblits 0.61
7e9o.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(3 up RBDs, state2)
 0.67 99.17 0.94 30-1227 EM 0.00 hetero-3-3-3-mer 27 x NAG HHblits 0.61
7f46.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab (state1, local refinement of the RBD, NTD and 35B5 Fab)
 0.01 99.17 0.94 30-1227 EM 0.00 hetero-2-1-1-mer 2 x NAG HHblits 0.61
7f46.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab (state1, local refinement of the RBD, NTD and 35B5 Fab)
 0.02 99.17 0.94 30-1227 EM 0.00 hetero-2-1-1-mer 2 x NAG HHblits 0.61